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ABSTRACT 
 
Jennifer Rice Stevenson: An Assessment of the Neurobiological and Behavioral Changes 
that Occur During Abstinence Following Chronic Alcohol Drinking 
(Under the direction of Dr. Clyde Hodge) 
 
Although many alcoholics experience periods of abstinence, most will relapse. Indeed, the 
inability to resist alcohol drinking is central to alcohol addiction. The emergence of negative 
affective states during abstinence is thought to be a key mediator of relapse behavior. The 
data presented here indicate that abstinence from voluntary alcohol drinking leads to the 
emergence of depression-like behavior and reductions in neurogenesis.  C57BL/6J mice 
were allowed to self-administer ethanol (10% v/v) vs H2O in the home cage for 28 days. 
Alcohol was then removed for 1-d or 14-d, and mice were tested in the forced swim test to 
measure depression-like behavior. After 14 days, but not 1 day of abstinence from alcohol 
drinking, mice showed a significant increase in depression-like behavior.  The significant 
increase in depression-like behavior during abstinence was associated with a reduction in 
neurogenesis. Chronic treatment (14-d) with the antidepressant desipramine during 
abstinence prevented both the emergence of depression-like behavior and the reduction in 
new neurons indicating that abstinence-induced depression is associated with structural 
plasticity in the hippocampus.  Alterations in CREB expression and CREB activation, as 
measured by CREB and pCREB immunoreactivity, have been linked to changes in alcohol 
reinforcement, as well as depression; therefore, the changes in CREB in response to 
desipramine or vehicle treatment were investigated during the abstinence period.  The most 
 iii
significant changes noted were in the CA3 subregion of the hippocampus which showed 
significant reduction in CREB and pCREB immunoreactivity due to 14-d abstinence, and 
complete prevention of this reduction by desipramine treatment. Dysregulation of the HPA 
axis is examined in this dissertation not only because it can lead to depression, but also 
because alcohol drinking, alcohol withdrawal, and alcohol abstinence are all associated with 
HPA axis dysregulation. Changes in the HPA axis as a result of 14-d abstinence were not 
evident. Overall, the results of this study support the conclusion that profound functional 
(i.e., behavioral) and structural changes occur during abstinence from alcohol use and 
suggest that antidepressant treatment may alleviate some of these pathological 
neurobehavioral adaptations.    
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CHAPTER I: INTRODUCTION 
 
ALCOHOLISM 
Alcoholism affects millions of people’s lives every day. Over 7% of the United States 
population is alcoholic, leading to annual costs of more than $180 billion (Harwood 2000).  
Alcoholism is characterized primarily by an inability to control alcohol drinking. Alcoholics 
experience craving for alcohol, a lack of ability to stop drinking once drinking has begun, 
physical dependence (withdrawal symptoms), tolerance, preoccupation with alcohol 
consumption, lack of interest in other life activities besides drinking alcohol, and continued 
alcohol use despite physical and psychological problems.  Withdrawal symptoms include 
autonomic hyperactivity, tremor, nausea or vomiting, anxiety, and seizure, while tolerance is 
defined as a need for more alcohol in order to obtain the same level of intoxication (Becker; 
NIAAA 1995).     
 Chronic consumption of alcohol leading to alcoholism produces many 
neuroadaptations and creates an allostatic state (Koob 2003). Among these changes that 
occur as a result of drinking are alterations in the brain reward and stress systems. These 
manifest themselves through neuroadaptations in the nucleus accumbens, amygdala, 
hippocampus, pre-frontal cortex, and many other regions. Neurotransmitter systems known 
to become dysregulated as a result of chronic drinking and alcohol abuse are dopamine, 
gamma-aminobutyric acid (GABA), glutamate, serotonin, and several neuropeptides (Koob 
et al. 1998). A crucial aspect of alcohol addiction is that alcoholics experience increased 
negative affect in the absence of alcohol (Koob and Le Moal, 1997. A major goal in the field 
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of alcohol research is understand these neuroadaptations that underlie the development of 
addiction.  
ABSTINENCE FOLLOWING ALCOHOL DRINKING 
 Although many alcoholics experience periods of abstinence, most will relapse. 
Indeed, the inability to resist alcohol drinking is central to alcohol addiction. The 
psychological and neurobiological factors that lead to relapse are an area of active 
investigation, and are the focus of this dissertation (Lowman C. et al., 2000; Li TK, 2000). In 
addition to the neuroadaptations that occur during active drinking periods, further 
neuroadaptations occur upon cessation of alcohol drinking as a result of the removal of a 
chronic stimulus (alcohol). These abstinence-induced neuroadaptations may lead to 
increased vulnerability for relapse (Figure 1). While the neurobiological consequences of 
acute alcohol withdrawal have been studied extensively, the central nervous system 
changes that occur during protracted withdrawal are not as well understood (Martinotti et al. 
2008). The emergence of negative affective states during abstinence is thought to be a key 
mediator of relapse behavior (Koob and Le Moal 1997). Surprisingly, very few pre-clinical 
studies have examined neurobiological and behavioral changes beyond the initial 72-hours 
of withdrawal. Moreover, the vast majority of studies examining the effects of cessation of 
alcohol drinking have done so in models of forced alcohol consumption. The effects of 
abstinence following free choice or voluntary drinking in a animal models are understudied. 
The primary goal of the work presented in this dissertation was to characterize the 
neurobiological and behavioral changes that occur during protracted abstinence following 
chronic voluntary alcohol drinking.  
COMORBIDITY OF ALCOHOLISM AND DEPRESSION 
Alcoholism and depression are two devastating diseases that often co-occur. Studies on 
depression among alcoholics show comorbidity rates as high as 42.2% (Schuckit et al. 
1997b), alcohol abuse and/or dependence are associated with a 2- to 4-fold increase in the 
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occurrence of depression (Grant and Harford 1995; Kessler et al. 1997). Moreover, rates of 
depression are significantly elevated among people who seek treatment for alcoholism 
(Lynskey 1998) and depressive symptoms including sadness, despair, sleep disturbances, 
altered endocrine functions, decreased energy, mental slowing, loss of concentration, 
pessimism, ideas of guilt and self-deprecation are common in alcohol dependence and 
abstinence (Garbutt et al. 1999). Unfortunately, when these two diseases co-occur, relapse 
to alcohol use is more likely and remission from depression is less likely (Greenfield et al. 
1998; Mueller et al. 1994). Importantly, depression that occurs during abstinence increases 
the likelihood of relapse in alcoholics, whereas prior-onset depression is not related to 
relapse (Hasin et al. 2002). Abstinence-related depression is thought to increase the chance 
of relapse because drinking may help people cope with negative emotions (Carpenter and 
Hasin 1998; Hasin and Grant 2002).  From a treatment perspective, the efficacy of 
antidepressant medications in treating a number of forms of depression is well validated; 
however the use of antidepressants in the treatment of alcoholism needs further study. 
There are a limited number of well-controlled studies on the efficacy of antidepressant use 
for alcoholics. However, clinical studies have demonstrated that both fluoxetine and 
desipramine are effective in reversing depression comorbid with alcoholism, and have 
shown modest success in preventing relapse (Le Fauve et al. 2004). 
While the clinical literature is rife with information regarding alcoholism and depression, 
preclinical studies examining the relationship between alcoholism and depression are 
lacking. A handful of studies have examined how genetic predisposition to high alcohol 
intake affects depression-like behavior and how genetic predisposition to depression-like 
behavior affects alcohol intake in rats, but the results have been inconsistent (Godfrey et al. 
1997; Overstreet et al. 1992; Vengeliene et al. 2005). Surprisingly, the effects of chronic 
drinking on depression-like behavior have not been studied. The work presented here 
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attempts to answer the question, “What are the neuroadaptations that occur during 
abstinence following voluntary drinking, and do these neurobiological changes increase 
vulnerability to the emergence of negative affective states?” While this dissertation in no way 
examines every possible mechanism by which abstinence can promote negative affect, this 
work focuses on an integrated mechanistic pathway of potential neuroadaptations during 
abstinence including alterations in the HPA axis and monoamine neurotransmitter systems, 
and resulting changes in intracellular signaling and synaptic structure. 
MONOAMINE HYPOTHESIS OF DEPRESSION 
 Monoamine dysregulation has long been hypothesized to underlie depression largely 
due to the efficacy of monoamine-reuptake inhibitors in treatment of depression (Delgado 
and Moreno 2000). Multiple classes of antidepressant drugs act to block the reuptake of 
monoamines including serotonin (5-HT) and norepinephrine (NE). While enhancement of 
monoamine neurotransmission promotes recovery for many depressed patients, the 
evidence supporting monoamine deficiency as the primary dysfunction in depression is 
lacking. Specifically, monoamine depletion techniques do not produce depression. Depletion 
of specific monoamines is pro-depressant only in patients currently taking a reuptake 
inhibitor for the depleted transmitter or in patients who are experiencing remission from 
depression after having taken a reuptake inhibitor for the depleted transmitter (Delgado and 
Moreno 2000; Stone et al. 2008). More recent hypotheses of mechanisms underlying 
depression cite neurotransmitter, neurotrophic, and neuroanatomical systems that can be 
modulated by monoamines and that may represent final common pathways of depressive 
agents and antidepressant treatments. The tricyclic antidepressant desipramine (a NE 
reuptake inhibitor) is administered during experiments described in the dissertation. While 
the primary mechanism of action of desipramine is inhibition of the reuptake of NE, our 
investigations into the mechanisms by which desipramine produces its positive behavioral 
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effects focused on examples of possible final common pathways such as gene transcription 
and structural plasticity, which are introduced below.  
CREB 
 Cyclic AMP-response-element-binding (CREB) protein is a transcription factor that 
has been shown to regulate the expression of many genes leading to long-term changes in 
cell and synaptic function and structure. CREB-dependent transcription is primarily 
regulated by kinase-induced phosphorylation of CREB at serine residue 133 (Ser-133) 
(Johannessen et al. 2004). A large number of kinases (e.g., PKA, PKB, PKC, MEK, ERK, 
MAPK, CaMK, etc.) can induce phosphorylation of CREB at Ser-133 (p-CREB) 
(Johannessen et al. 2004), which indicates involvement of numerous neurotransmitter-
signaling pathways. Changes in the level of p-CREB can in turn alter expression of any 
number of CREB target genes (i.e., genes with CRE sites in their promoter regions). CREB 
target genes are found in a variety of systems including: metabolism, transcription (e.g., 
EGR-1, c-FOS, JUND), neuropeptides (CRF, galanin, NPY, vasopressin, dynorphin), and 
growth factors (BDNF, TNFalpha) (Mayr and Montminy 2001). Data have shown that 
changes in BDNF expression in the hippocampus results in parallel changes in hippocampal 
neurogenesis (see below) and may be a mechanism of action of antidepressant treatments 
(Sairanen et al. 2005). Accumulating evidence also suggests that CREB (and its target 
genes) regulates alcohol dependence and withdrawal and may underlie anxiety associated 
with alcohol withdrawal (Pandey 2003). Alterations in CREB expression and CREB 
activation, as measured by CREB and pCREB immunoreactivity, in several brain regions 
have been linked to changes in alcohol reinforcement, as well as depression (Carlezon et al. 
2005; Pandey 2004). Identifying specific conditions that alter CREB activity has fundamental 
importance for understanding a variety of neural functions and disorders including 
alcoholism and depression.     
NEUROGENESIS 
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The discovery of new neurons in the adult brain has created a completely new area of 
neuroscience research. Neurogenesis, the proliferation of neural progenitor cells (NPC), in 
the adult brain was originally discovered in 1965 (Altman and Das 1965), but was not 
accepted until recently. Although NPC are found throughout the adult mammalian brain, the 
majority of adult neurogenesis appears to occur in the subventricular zone (SVZ) of the 
lateral ventricles and the dentate gyrus subgranular zone (DG-SGZ) of the hippocampus 
(Gage 2002; Ming and Song 2005). The function of adult neurogenesis has so far been 
implicated in learning and memory, mood, and association of sensory information (Duman et 
al. 2001; Gould 1999; Gross 2000; Kempermann et al. 1998; van Praag et al. 1999a; van 
Praag et al. 1999b). In general, evidence suggests that new neurons in the adult brain 
contribute to synaptic plasticity (Snyder et al. 2001) and the more general ability of the 
organism to adapt to changing circumstances (Kempermann 2002). Enriched environment 
and exercise have been associated with increased neurogenesis, while stress and alcohol 
exposure have been associated with decreased neurogenesis (Gage 2000; Gould 1999; 
Nixon and Crews 2002). Given that neural stem cells that have divided and differentiated 
into neurons produce 6 percent of the total granule cell population each month in the adult 
hippocampus, the survival and proliferation of these cells is crucial for proper hippocampal 
function (Cameron and McKay 2001).  
ALCOHOL AND NEUROGENESIS 
Alcohol has long been known to produce hippocampal neuropathy and hippocampal-
associated cognitive deficits (Brandt et al. 1983; Collins et al. 1996; Obernier et al. 2002; 
Sullivan et al. 2000; Walker et al. 1980). Nixon and Crews (Nixon and Crews 2002) have 
seen a 53% reduction in neural stem cell proliferation in rats as a result of a 4-day binge 
producing extremely high blood alcohol levels, and Herrera et al. (Herrera et al. 2003) have 
seen decreases in neural stem cell proliferation as a result of lower blood alcohol levels. 
Additional data suggest that not only proliferation, but also survival of neural progenitor cells 
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is decreased by ethanol exposure. These data on neurogenesis are consistent with the cell 
loss and hippocampal deficits associated with alcoholism.  
 The majority of the studies on the effects of alcohol exposure on neurogenesis have 
used animal models of forced ethanol consumption in which animals either consume a liquid 
diet containing ethanol or are intra-gastrically injected with ethanol. Both of these methods 
of ethanol exposure can be quite stressful for the animal.  Given that humans generally self-
administer alcohol voluntarily, it is important to examine the effects of voluntary ethanol 
consumptions on neurogenesis in an animal model.  
A full characterization of the effects of chronic voluntary ethanol drinking on 
neurogenesis can be achieved by evaluating different markers for neurogenesis and 
differentiation of neural progenitor cells at different time points following voluntary drinking in 
mice. Several different immunohistochemical markers have been validated for use in 
studying adult neurogenesis. A common way of measuring neurogenesis is with the 
thymidine analog bromo-deoxyuridine (BrdU). BrdU can be injected peripherally and will 
then be incorporated into DNA similarly to thymidine when cells are replicating their DNA 
and dividing. In this way, BrdU labels cells in the brain that have divided. When brains are 
studied shortly after BrdU is injected, BrdU can serve as a marker for proliferating cells. By 
studying brains several weeks after BrdU injections, one can evaluate the number of BrdU-
labeled cells that have survived since the time of labeling. By 28-days after BrdU injection, 
BrdU-labeled cells have migrated into the granule cell layer of the hippocampus and have 
begun to express proteins that indicate whether they are differentiating into neurons or glia. 
Cells that co-express BrdU and neuronal-specific nuclear protein (NeuN) are neural 
progenitor cells that have survived and are differentiating into neurons, and cells that co-
express BrdU and glial fibrillary acidic protein (GFAP) are neural progenitor cells that have 
survived and are differentiating into glial cells. Additionally, antibodies to proliferating cell 
nuclear antigen (PCNA) can be used to immunohistochemically label proliferating cells, and 
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antibodies to doublecortin (DCX) can be used to immunohistochemically label immature 
neurons. DCX labeling, therefore, can indicate the number of new cells that have 
differentiated into neurons. Using these immunohistochemical techniques at different time 
points following voluntary alcohol drinking, one can characterize ethanol’s effects on 
neurogenesis. 
DEPRESSION AND NEUROGENESIS 
Changes in hippocampal neurogenesis have been demonstrated to be related to 
depression, making neurogenesis is an interesting candidate as a mechanism underlying 
alcohol-related depression (Duman et al. 2000; Jacobs et al. 2000). Decreased hippocampal 
volume has been noted in clinical studies of depression patients (Davidson et al. 2002), and 
it has been suggested that dysfunction of the hypothalamic-pituitary-adrenal (HPA) axis 
leads to increased glucocorticoid levels in the hippocampus thereby causing neuronal cell 
loss (Gold et al. 1988; Sapolsky 2000). Jacobs et al. (Jacobs et al. 2000) have suggested 
that decreased neurogenesis is responsible for changes in hippocampal volume. Stress is 
known to cause dysfunction of the HPA axis, to increase glucocorticoid production, and to 
precipitate depression. Huang et al. (Huang et al. 2004) identified the dentate gyrus of the 
hippocampus as a region that shows c-Fos activation following post-shock escape testing in 
mice with learned helplessness. Inescapable stress, stress caused by a predatory odor, and 
corticosterone have all been shown to reduce neurogenesis, and stress is thought to 
precipitate depression (Cameron and Gould 1994; Gregus et al. 2005; Malberg and Duman 
2003; Tanapat et al. 2001). Additional evidence supporting the neurogenesis hypothesis for 
depression includes the effects of antidepressant therapy on neurogenesis. Chronic 
administration of antidepressants causes increases neurogenesis, as does 
electroconvulsive therapy (Madsen et al. 2000; Malberg et al. 2000). Moreover, 
antidepressant treatment is ineffective in the absence of neurogenesis (Santarelli et al. 
2003).  
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HPA AXIS DYSREGULATION 
 The hypothalamic-pituitary-adrenal (HPA) axis is the primary effector limb of the 
physiological stress system. It is via this axis that perceived stressors are transduced into a 
physiological response. Briefly, when the brain perceives a stressor, the hypothalamus 
releases corticotropin-releasing factor (CRF), which stimulates the pituitary gland to release 
adrenocorticotropic hormone (ACTH). ACTH, then, stimulates the adrenal cortex to release 
glucocorticoids (cortisol is the primary glucocorticoid in humans; corticosterone is the 
primary glucocorticoid in rodents). Glucocorticoids circulate throughout the organism with 
widespread effects on peripheral organs, as well as in the brain. The stress response 
evolved as a homeostatic mechanism that allows organisms to properly respond to a 
stressor and then return to basal physiological functioning via inhibitory feedback 
mechanism. Feedback inhibition occurs when glucocorticoids bind to glucocorticoid type II 
receptors (GR) which inhibit release of CRF and ACTH (Tsigos and Chrousos 2002).  
Activity of the HPA axis is critical for the survival of an organism, yet over-activation of the 
HPA axis can lead to the emergence of severe physical and mental illness (Sapolsky 1996). 
Chronic activation of the HPA axis can lead to dysregulation of activating and inhibitory 
mechanisms at each level of the HPA axis. In addition to the inherent feedback inhibition, 
the HPA axis can be inhibited by extra-hypothalamic structures in the brain, including the 
cortex and the hippocampus (McEwen 2001; Sapolsky 2000).  Because of this, disruptive 
hippocampal neuroadaptations in response to stress can potentiate HPA axis dysregulation. 
Disruption of HPA feedback inhibition can lead to a state known as hypercortisolemia, in 
which glucocorticoid secretion is increased and pituitary and adrenal gland sizes are 
increased. In response to elevated glucocorticoid levels, GR are downregulated, causing 
further impairment of feedback inhibition Stone et al., 2008). Chronic overactivation of the 
HPA axis can precipitate depression. In fact, hypercortisolemia in depressed patients is one 
of the most consistent findings in psychiatry (Nemeroff 1996). Moreover, one of the 
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mechanisms by which monoamine reuptake inhibitors treat depression is by increasing 
glucocorticoid receptor expression in the hippocampus (Het and Wolf 2007). 
 Dysregulation of the HPA axis is examined in this dissertation not only because it 
can lead to depression, but also because alcohol drinking, alcohol withdrawal, and alcohol 
abstinence are all associated with HPA axis dysregulation (Sillaber and Henniger 2004).  
The relationship between stress and alcohol is integral to alcohol addiction. Both alcohol 
and alcohol withdrawal can produce hyperactivity of the HPA axis, leading to enhanced 
sensitivity to stressors, while abstinence following chronic alcohol drinking is associated with 
hypoactivity of the HPA axis. Both over- and under-activation impair the ability to properly 
cope with stressors. The inability to cope with stress is frequently reported as a reason for 
initiation of alcohol drinking and relapses to drinking following periods of abstinence; thus, 
HPA dysfunction can greatly enhance one’s vulnerability to alcohol addiction (Adinoff et al. 
1998; Rivier et al. 1996). The HPA axis, therefore, may be a mechanism underlying the 
relationship between alcoholism and depression.  
CONCLUSIONS AND RATIONALE 
 Although comorbidity of alcoholism and affective disorders is major clinical issue, 
little is known about the mechanisms that are responsible for this relationship. The work 
presented in this dissertation describes a model for investigating depression-like behavior 
that emerges during abstinence following chronic voluntary drinking in mice. Because of the 
known effects of alcohol on CREB and neurogenesis, these factors are examined as 
possible mechanisms by which alcohol-related depression develops. Additionally, the HPA 
axis is investigated as a system that may become dysregulated during abstinence following 
chronic alcohol drinking, creating a greater vulnerability to negative affective states.  
 
 
 
 
 
 
 
 
 
 
 
CHAPTER II: ABSTINENCE FOLLOWING ALCOHOL DRINKING PRODUCES 
DEPRESSION-LIKE BEHAVIOR AND REDUCED HIPPOCAMPAL NEUROGENESIS IN 
MICE 
 
INTRODUCTION 
Alcoholism and depression are two of the most costly and widespread neuropsychiatric 
disorders worldwide.  In the United States, the prevalence of a lifetime history of depression 
in alcohol dependent individuals has been reported to be about 42% (Miller et al. 1996; 
Schuckit et al. 1997b) but comorbidity rates from 5% to as high as 80% have been noted in 
some studies (Pettinati 2004). Alcohol abuse and/or dependence are also associated with a 
2-4 fold increase in depression rates (Grant and Harford 1995; Kessler et al. 1997). 
Moreover, rates of depression are significantly elevated among people who seek treatment 
for alcoholism (Lynskey 1998) and depressive symptoms are common in alcohol 
dependence and abstinence (Garbutt et al. 1999). When alcoholism and depression co-
occur, relapse to alcohol use is more likely and remission from depression is less likely 
(Greenfield et al. 1998; Mueller et al. 1994).   
Emerging evidence indicates that features of both alcoholism and depression may be 
mediated by changes in adult hippocampal neurogenesis (Crews and Nixon 2003; Duman et 
al. 2000; Jacobs et al. 2000). For example, several antidepressant treatments increase 
neurogenesis (Malberg et al. 2000; Santarelli et al. 2003; Warner-Schmidt and Duman 
2006), while stress, which is widely thought to precipitate depression, reduces neurogenesis 
(Cameron and Gould 1994; Gregus et al. 2005; Malberg and Duman 2003; Tanapat et al. 
2001). In addition to stress, alcohol has been shown to reduce neurogenesis. Studies have 
shown that high levels of alcohol exposure can reduce survival and proliferation of neural 
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progenitor cells (NPC) (He et al. 2005; Herrera et al. 2003; Nixon and Crews 2002). 
Withdrawal from alcohol exposure is associated with time-dependent increases and 
decreases in proliferation of NPCs (Nixon and Crews 2002). These data led us to 
hypothesize that decreased hippocampal neurogenesis may be a neurobiological 
mechanism that contributes to the co-occurrence of alcoholism and depression.  
Factors that reduce neurogenesis, such as stress and dysregulation of monoamines 
(Jacobs et al. 2000), have been shown to increase depression-like behavior (Hwang et al. 
1999; Johnson et al. 2006; Plaznik et al. 1988; Prince and Anisman 1984) as measured by 
the forced swim test (Aberg et al.) in rodents (Porsolt et al. 1977). Major classes of 
antidepressants including tricyclic antidepressants, selective serotonin reuptake inhibitors, 
and monoamine oxidase inhibitors show efficacy in the FST (Cryan et al. 2005; Dalvi and 
Lucki 1999; Lucki et al. 2001)  and increase hippocampal neurogenesis (Malberg et al. 
2000).  Moreover, antidepressant efficacy in rodent behavioral models may require 
hippocampal neurogenesis (Santarelli et al. 2003).  It is not known if antidepressants 
reverse alcohol-induced changes in neurogenesis or depression-like behavior. 
Important clinical evidence indicates that depression that emerges during abstinence 
following alcohol drinking has a greater negative impact on relapse rates than pre-existing 
depression (Hasin et al. 2002), yet preclinical studies on this topic are lacking. In this study, 
we report the development and validation of a novel model of alcohol abstinence-induced 
depression-like behavior in mice as measured by the FST (Porsolt et al. 1977).  Using this 
model, we demonstrate that abstinence-induced changes in depression-like behavior are 
associated with reduced hippocampal neurogenesis, and that this deficit is reversed in 
association with the positive behavioral effects of antidepressant treatment.    
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METHODS  
Animals 
Adult male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were singly 
housed in standard Plexiglas cages with Purina Rodent Chow and fluid always available. 
Mice were 9 weeks old at the start of all experiments, and weighed between 22-26g at the 
beginning of the experiments.  At the end point of experiments, mice weighed between 25-
31g.  The vivarium was maintained at 27ºC on a reverse 12:12 light-dark cycle (lights on at 
22:00). Animals were under continuous care and monitoring by veterinary staff from the 
Division of Laboratory Animal Medicine at UNC-Chapel Hill, and all procedures were also 
carried out in accordance with the NIH Guide to Care and Use of Laboratory Animals 
(National Research Council, 1996) and institutional guidelines.  
Experimental Procedures 
In the first set of experiments, mice were weighed and handled daily for 7 days prior to 
experiments to facilitate adaptation to the laboratory (Figure 3A). All mice were administered 
BrdU (see below) once per day for 3 days.  Animals were then randomly assigned to 
experimental groups.  Experimental groups were as follows: alcohol-drinking mice were 
allowed to voluntarily consume alcohol or water for 28 days using a two-bottle drinking 
procedure (see below) and were behaviorally tested after 1 (n=12) or 14 (n=12) days of 
abstinence; water-only controls (n=12) had access to two bottles of water for 28 days and 
then were behaviorally tested one day later.  Behavior was evaluated in the forced swim 
test.  Mice were returned to the vivarium after behavioral testing and brains were removed 
24 hours later (Figure 3A). 
In the second set of experiments, mice were allowed 7 days to adapt to handling and the 
laboratory environment (Figure 3B).  Mice were randomly assigned to the following 
treatment conditions:  two groups of alcohol-drinking mice voluntarily consumed alcohol or 
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water for 28 days using a two-bottle drinking procedure (see below); one group of water-only 
controls had access to two bottles of water for 28 days.  Alcohol-drinking mice then received 
injections of either vehicle (n=12) or desipramine (n=12, see Drugs below) during a 14 day 
abstinence period.  Water-only control mice received daily injections of either vehicle (n=12) 
or desipramine (n=12) in parallel to the alcohol-abstinent mice. Water-only mice that 
received vehicle injections served as a control for alcohol exposure and injection stress.  In 
addition, this group allowed us to rule out potential effects of aging on neurogenesis.  The 
first injection was given the same day that alcohol bottles were removed from the cages, so 
that the 14th injection occurred 13 days after removal of alcohol. Behavior of all mice was 
evaluated in the forced swim test 1 day after the final desipramine injection (Figure 3B).  
Desipramine was not administered on behavioral test days, in order to examine the effects 
of chronic, but not acute, antidepressant treatment.  Animals were sacrificed 24-hr after 
behavioral testing (Figure 3B).  
An additional experimental group was included in immunohistochemical studies in which 
animals were sacrificed at the end of their 28th day of alcohol drinking (0 days of 
abstinence). This group was not included in behavioral studies to avoid potential 
confounding effects of acute alcohol.   
Two-Bottle Drinking Procedure 
 During the one week period of acclimation and handling, water was the only fluid 
available. All fluids were presented in the home cage via 50mL plastic centrifuge bottles with 
stainless steel sipper tubes. Alcohol-drinking mice were then given access to one bottle of 
water and one bottle of alcohol (10%v/v) as previously described (Hodge et al. 1999). 
Animals were weighed and the fluid levels in the bottles were monitored to the nearest 0.5 
mL at 24-hr intervals to determine daily fluid intake (mL and g/kg). The position (left-right) of 
the alcohol and water bottle was changed each day to control for side preferences. Mice 
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were given access to alcohol for 28 days. Control animals had access to two bottles of water 
for the same duration (28 days). On day 23 of alcohol drinking, tail blood was collected and 
analyzed for blood alcohol level (File et al.). On the final day of drinking, the alcohol solution-
containing bottle was removed from the cages of alcohol drinkers, and one water bottle was 
removed from the cages of controls; thus, during abstinence only one bottle was on each 
cage.   
Blood Alcohol Determination 
 BAL was measured from tail vein blood samples taken between 2 and 3 hours into 
the dark cycle as an index of alcohol intake.  Individual blood samples (approx. 20 µl) were 
centrifuged and 5 µl of plasma from each sample was used to determine alcohol 
concentration using an AM1 Alcohol Analyzer (Analox Instruments, Lunenburg, MA).  
Forced Swim Test Procedure 
Depression-like behavior was assessed in mice using the FST (Porsolt et al. 1977). 
Mice were placed in a 2000mL beaker containing 1300mL of water maintained at 23-25°C 
for 6 minutes. Behavior was videotaped for later analysis by two trained observers who were 
blind to the treatment conditions. The duration of immobility during the last 4 minutes of the 
FST was measured during a single session as an index of depression-like behavior. Mice 
were considered immobile if they were completely still except for small movements of the 
paw made only to keep the mouse afloat, and not producing any noticeable propulsion of 
the mouse.   
Open-field anxiety testing 
Spontaneous locomotor activity was measured in brightly lit (500 lux) chambers (43 × 43 
cm) as described (Hodge et al. 2002).  For assessment of activity in the center of the field, 
the chamber floor was divided post hoc into a center zone (21 × 21 cm; center equidistant 
from all four walls of the chamber) and a periphery zone (the remaining area of the floor). 
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Distance traveled and time spent in each area was calculated from the locomotor activity 
data. After each test session, the equipment was cleaned with acetic acid (2%) to limit 
animal odors. 
Drugs 
Bromo-deoxyuridine (BrdU) (Sigma-Aldrich, St. Louis, MO) (300 mg/kg, 15 mL/kg, 
dissolved in saline, IP), used here as a marker of surviving neural progenitor cells, was 
administered once a day for three days before the onset of alcohol drinking.  Where 
indicated, mice were injected with desipramine-HCl (Sigma-Aldrich, St. Louis, MO) (15 
mg/kg, 10 mL/kg, IP) or vehicle (0.9% saline, 10mL/kg, IP) once per day for 14 days during 
abstinence. The antidepressant desipramine was used in this study because it has been 
shown to be highly effective (more so than fluoxetine) in the FST in C57BL/6J mice (Lucki et 
al. 2001). This particular dose of desipramine was selected based on its efficacy in the FST 
and its ability to produce hippocampal neuroadaptive changes (Lucki et al. 2001; Thome et 
al. 2000). 
Tissue Fixation and Sectioning  
Animals were deeply anesthetized with pentobarbital (60 mg/kg, 10 mL/kg, IP) and 
perfused transcardially with 0.1 M phosphate buffered saline (PBS) followed by 4% 
paraformaldehyde. The brains were removed from the skull and placed in the same fixative 
solution for at least 24-hr before being washed with PBS and sliced on a Leica VT 1000S 
vibrating microtome into 40 µm sections. The free-floating sections were stored in 
cryoprotectant at -20°C until immunohistochemistry was performed.  
Immunohistochemistry 
Tissue was washed in PBS, and then treated with 0.6% hydrogen peroxide to block 
endogenous peroxidase activity. Tissue was incubated for 1-hr in a blocking solution (3% 
horse serum, 0.1% Triton-X, 0.1M PBS) before incubation in the primary antibody. Sections 
were incubated in the anti-PCNA antibody (EMD Biosciences Inc, San Diego, CA; dilution 
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1:400) overnight at 4°C or in the anti-doublecortin antibody (Santa Cruz Biotechnology Inc, 
Santa Cruz, CA; dilution: 1:1000) for 48 hrs at 4°C. The following day, tissue sections were 
rinsed in PBS before incubation in the appropriate secondary antibody (Vector Laboratories, 
CA) for 1-hr. Tissue was then processed with avidin-biotin complex (Vector ABC kit, Vector 
Laboratories, CA) and immunoreactivity was visualized with DAB (Polysciences, Inc, PA). 
Tissue sections were then rinsed in PBS and, in the case of PCNA immunohistochemistry, 
counterstained with toluidine blue before sections were mounted onto slides.  
For BrdU immunohistochemistry, tissue was prepared according to the method of 
Nixon and Crews (Nixon and Crews 2002). Tissue was washed in PBS, and then treated 
with 0.6% hydrogen peroxide to block endogenous peroxidase activity. Next, tissue was 
incubated in 50% formamide/2X SSC for 2 hrs at 65°C, then in 2N HCl for 1 hr at 37°C. After 
neutralizing in 0.1M boric acid, tissue was rinsed in PBS, then incubated overnight at 4°C in 
primary antibody (anti-BrdU: Accurate Chemical and Scientific Corp., NY; dilution 1:400). 
The following day was performed as described above for PCNA immunohistochemistry. 
Antibody dilutions were chosen based on dilution curves, and antibody specificity was 
verified secondary only controls in all immunohistochemical assays.  
Analysis of Immunohistochemistry 
For BrdU and PCNA immunohistochemistry, immunopositive cells in the dentate 
gyrus were counted manually with an oil immersion lens (Plan Apo 60x oil; numerical 
aperture, 2.0; Olympus Optical, Melville, NY). Profile counting methodology was used as it 
has previously been shown that profile counting and stereological estimations show identical 
results in percentage change (Crews et al. 2004). Moreover, stereology may not be 
appropriate for quantifying BrdU + cells, because they are not homogeneously distributed 
throughout the dentate (Popken and Farel 1997). Cell counts are expressed as the number 
of immunopositive cells per dentate gyrus section.  For doublecortin immunohistochemistry, 
image analysis software (Bioquant Nova Advanced Image Analysis; R&M Biometric, 
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Nashville, TN) was used to measure optical densitometry of the staining. Densitometry 
measurements are divided by the area of the section and expressed as pixels/mm2. Every 
sixth section within stereotaxic range from Bregma -1.46mm to Bregma -2.54mm (Paxinos 
and Franklin 2001) was analyzed to generate an average cell count or pixel density for each 
subject. Experimenter performing immunohistochemical analyses was blind to the treatment 
condition of the subjects. Desitometry analyses were repeated during a subsequent 
Bioquant session to ensure that results replicated.   
Immunofluorescence 
Triple-label confocal microscopy was performed according to Nixon and Crews 
(2004).  The colocalization of BrdU with neuronal-specific nuclear protein (NeuN) or glial 
fibrillary acidic protein (GFAP) proteins was used to characterize the fate of surviving NPCs. 
Tissue was washed in PBS, then incubated in a blocking buffer. Tissue was then incubated 
in a solution containing primary antibodies (rat anti-BrdU, Accurate, Westbury, NY; dilution 
1:400; mouse anti-NeuN, Chemicon, Temecula, CA; dilution 1:500; rabbit anti-GFAP, Dako, 
Glostrup, Denmark; dilution 1:2000).  The following day, tissue was rinsed in PBS, then 
incubated in the dark with fluorescent-coupled secondary antibodies appropriate for each 
primary antibody. Tissue was then rinsed in PBS and mounted onto slides, taking care to 
protect the sections from the light. Slides were coverslipped using ProLong Anti-Fade 
reagent (Molecular Probes, OR).   
Visualization and Analysis of Immunofluorescence.   
Triple-label immunofluorescence was visualized with a Zeiss (Oberkochen, 
Germany) Axiovert LSM510 confocal microscope on multitrack setting with a water 
immersion lens (C-Apochromat 40x/1.2 W corr). Colocalization was confirmed by confocal 
microscopy optimized for the analysis of tissue sections. For each subject, 50 BrdU-labeled 
cells were analyzed for colocalization with GFAP or NeuN. Percentages of BrdU-labeled 
cells that colabeled with each cell type were determined. The 50 cells were selected from 
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several fields in a minimum of five tissue sections. Z-plane section images (512 x 512 pixels) 
were collected at <1 µm thickness and then analyzed using LSM Image Examiner software 
(Zeiss). The criteria for co-labeling included appropriate morphology and more than two Z-
plane images of co-positive staining. 
Statistical Analyses 
In the first set of experiments, between subjects one-way analysis of variance 
(ANOVA) were used to analyze changes in behavior and immunohistochemistry. Post-hoc 
Dunnett’s tests were conducted to determine if treated groups were different from control. In 
the second set of experiments, between subjects two-way ANOVA were used to analyze 
changes in behavior and immunohistochemistry. Post-hoc Tukey tests were used to 
determine between-group differences. Statistical significance was always defined as p<0.05.   
 
RESULTS 
Abstinence following Alcohol Drinking is Associated with an Increase in Depression-
Like Behavior 
 To determine if abstinence following alcohol drinking is associated with changes in 
depression-like behavior, FST performance of water-only control mice was compared to 
mice that consumed alcohol for 28 days followed by 1 or 14 days of abstinence.   
Alcohol exposed mice voluntarily consumed average of 17.8 ±1.0 g/kg/day of alcohol (10% 
v/v) in the home-cage for 28 days, which resulted in peak blood alcohol levels of 112.8±7.4 
mg/dL.  Total fluid intake did not differ between water and alcohol exposed mice (data not 
shown).  One way ANOVA on FST data showed a significant main effect of exposure 
condition [F(2,33)=3.53, p<0.05] that was due to a 36% increase in immobility following 14 
days of abstinence as compared to water-only controls (p<0.05, Dunnett’s test).  No 
significant increase in immobility was evident 1 day after cessation of alcohol drinking 
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(Figure 4). These data show for the first time that alcohol drinking, followed by abstinence, 
leads to an emergent increase in depression-like behavior.  
Abstinence following Alcohol Drinking is Associated with a Transient Increase in 
Anxiety-Like Behavior 
 Anxiety-like behavior was evaluated by measuring the amount of time spent in the 
center of an open field. A one way ANOVA comparing water mice to mice that drank alcohol 
for 28 days followed by 1 or 14 days of abstinence demonstrated a significant difference in 
time spent in the center of an open field [F(2,33)=13.33, p<0.001] (Table 1). A significant 
decrease in the amount of time spent in the center of an open field was evident in mice after 
1 day of abstinence (p<0.05, Dunnett’s test) but not 14 days of abstinence (p>0.05, 
Dunnett’s test). These data indicate a temporary increase in anxiety-like behavior after 1 day 
of abstinence that disappears by 15 days of abstinence. Overall locomotor activity was 
analyzed 1 or 14 days after the removal of alcohol access. A one way ANOVA showed an 
overall difference in locomotor activity [F(2,33)=4.26, p=0.02] (Table 1); however post hoc 
comparisons revealed that neither alcohol treatment differed from control (p<0.05, Dunnett’s 
test).  
Survival and Differentiation of Neural Progenitor Cells 
Survival of hippocampal NPCs is reduced by exposure to forced alcohol liquid diet in 
rats that causes high blood alcohol levels (Herrera et al. 2003). However the effects of 
abstinence following chronic voluntary drinking on the survival of NPCs are not known. BrdU 
was injected before the onset of drinking in order to assess the number of dividing cells that 
survived until the brains were removed. There was no significant difference [F(2,29)=1.67, 
p=0.207] in the number of BrdU-labeled cells per dentate gyrus that remained after 1 or 14 
days of abstinence following chronic voluntary drinking compared to water-only controls 
(Figure 5A). Representative images of BrdU immunohistochemistry in the dentate gyrus are 
shown (Figure 5B). These results indicate that neither short term nor protracted abstinence 
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affects the survival of NPCs in this model of alcohol consumption.  Although no change in 
the number of surviving BrdU-labeled cells was evident, the number of surviving NPCs that 
became neurons or glia could have been affected. Triple label immunofluorescence, 
however, revealed that the remaining BrdU-labeled cells underwent neuronal and glial 
differentiation at the expected rates (Nixon and Crews 2004). Of the BrdU-labeled cells 
analyzed from alcohol drinkers (n=50 cells/animal) and water-only controls (n=50 
cells/animal), 89 and 92% colocalized with NeuN in the dentate gyrus, respectively. 
Representative immunofluorescence in the dentate gyrus is shown (Figure 5C and 5D). 
These data indicate chronic voluntary drinking does not affect the percentage of neuronal 
differentiation of surviving NPCs.  
Proliferation of Neural Progenitor Cells  
Although survival of NPCs was unchanged by voluntary alcohol drinking and 
abstinence, it is possible that other stages of neurogenesis, such as proliferation, were 
affected.  Previous studies have demonstrated biphasic alterations in NPC proliferation 
associated with alcohol exposure and withdrawal (Aberg et al. 2005; Crews et al. 2004; He 
et al. 2005; Nixon and Crews 2002). This study examined the effects of 0 days, 1 day, and 
14 days of abstinence following chronic voluntary drinking on proliferation of NPCs, using 
immunohistochemical analyses of PCNA expression. PCNA is a protein expressed on the 
nuclei of cells in the G1/S phase, therefore, PCNA immunoreactivity can be used to 
determine the number of cells undergoing proliferation in the hippocampus. To determine if 
abstinence from chronic drinking (and depression-like behavior) is associated with changes 
in NPC proliferation, serial sections of hippocampus were immunolabeled with proliferating 
cell nuclear antigen (PCNA), which is a cell cycle specific nuclear protein belonging to the 
replication complex that permits DNA synthesis needed for G1 to S transition(Krude 1999; 
Yew et al. 2001) and correlates with the proliferative state of cells (Celis et al. 1987). One 
way ANOVA comparing PCNA cell counts from alcohol drinking mice to water-only control 
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mice revealed a main effect [F(3,36)=6.5, p=0.001]. Follow up comparisons showed that 
abstinence following alcohol drinking for 14 days produced a significant decrease in NPC 
proliferation (p<.05, Dunnett’s test) as indexed by the number of PCNA labeled cells, while 0 
days and 1 day of abstinence did not produce a change in PCNA immunoreactivity (Figure 
6A). Representative photomicrographs illustrating PCNA immunoreactivity in the dentate 
gyrus are shown in Figure 6C. These results indicate that 14 days of abstinence following 
voluntary drinking leads to a decrease in the proliferation of NPCs in the dentate gyrus.  
Number of Immature Neurons 
Another approach to assessing neurogenesis is to examine the number of immature 
neurons in the dentate gyrus. Doublecortin immunohistochemistry can be used to determine 
the density of cells in the hippocampus that have proliferated, survived, differentiated into 
neurons, and begun to develop neurites (Couillard-Despres et al. 2005; Rao and Shetty 
2004). A main effect was revealed by a one way ANOVA comparing alcohol drinking 
animals to water-only controls [F(3,40)=8.2,p=0.001]. Similar to results from PCNA 
immunohistochemistry, the density of doublecortin immunoreactivity was significantly 
decreased following 14 days (p<0.01, Dunnett’s test), but not 0 or 1 day of abstinence 
following alcohol drinking relative to control (Figure 6B). Representative photomicrographs 
illustrating DCX immunoreactivity in the dentate gyrus are shown in Figure 6D. These data 
suggest that the number of new neurons in the dentate gyrus is reduced following 14 days 
of abstinence following voluntary drinking.   
Antidepressant Treatment during Abstinence  
 To determine if the emergence of depression-like behavior during abstinence can be 
prevented by administration of antidepressant medication, mice were given a single injection 
of desipramine each day for 14 days beginning the day alcohol was removed from the home 
cage. The day after the last desipramine injection, mice were tested in the FST. 
Desipramine was also used here to validate that the increase in immobility in the FST was a 
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depression-related behavior. Results indicated that chronic desipramine treatment 
prevented the emergence of depression-like behavior in mice that were treated with the 
antidepressant during two weeks of abstinence following chronic drinking. Antidepressant 
treatment had no effect on the behavior of mice with no history of drinking. A two-way 
ANOVA found a significant interaction between alcohol drinking history and antidepressant 
treatment [F(1,41)=9.74, p=0.003]; there was no main effect of alcohol or desipramine 
alone. Post-hoc multiple comparison procedures showed that immobility was increased in 
ethanol drinking mice relative to water controls under the vehicle condition (p=0.007, Tukey 
test), indicating that abstinence following chronic drinking was associated with increased 
depression-like behavior.  Within ethanol-drinking mice, desipramine treatment significantly 
decreased immobility in the FST (p=0.008, Tukey test), demonstrating that desipramine 
prevents increases in depression-like behavior following abstinence from chronic drinking 
(Figure 7A). Moreover, alcohol-exposed mice that received desipramine treatment did not 
differ from water controls, indicating that the depression-like behavior that emerged during 
abstinence was fully blocked by the antidepressant desipramine.  
 A two-way ANOVA revealed that anxiety as measured by time spent in the center of 
an open field did not differ between water and alcohol drinking groups [F(1,41)=0.62, 
p=0.43], or between vehicle of desipramine treated groups [F(1,41)=0.40, p=0.53]. 
Additionally, there was no interaction between drinking history and desipramine treatment 
[(F1,41)=3.32, p<0.08] (data not shown). These data indicate that neither 14 days of 
abstinence, nor desipramine treatment alter the amount of time spent in the center of an 
open field. Overall locomotor activity was also measured. A two-way ANOVA revealed a 
significant effect of alcohol [F(1,41)=5.27, p=0.02], and a significant effect of desipramine 
[F(1,41)= 10.60, p=0.002], but no interaction between drinking history and desipramine 
treatment [F(1,41)=1.39, p=0.25] (data not shown). These data suggest that 14 days of 
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abstinence from alcohol drinking leads to an overall decrease in locomotor activity, and that 
14 days of desipramine treatment leads to an overall increase in locomotor activity.  
 Because studies have indicated that increasing neurogenesis may be a mechanism 
by which antidepressants produce their behavioral effects, we tested the ability of 
desipramine to block the decrease in neurogenesis associated with the emergence of 
depression-like behavior following two weeks of abstinence from chronic drinking. 
Immunohistochemical analyses of PCNA and DCX expression were performed to measure 
proliferation of NPCs and the number of immature neurons, respectively, 14 days after 
cessation of chronic drinking.  Two-way ANOVA revealed no main effect of alcohol drinking 
or antidepressant treatment alone on the number of PCNA labeled cells. Importantly, 
however, there was a significant interaction between alcohol drinking history and 
desipramine treatment [F(42,1)=4.71, p=0.036].  Post-hoc multiple comparisons (Tukey test) 
showed that the interaction was due to a significant reduction in the number of PCNA 
labeled cells in alcohol drinking mice as compared to water controls in the vehicle condition 
(p=0.012, Figure 7B). The number of PCNA positive cells following desipramine treatment 
was not different from water controls (Figure 7B). These data indicate that abstinence 
following chronic drinking decreases the number of proliferating cells in the dentate gyrus, 
and that this decrease is blocked by administration of desipramine during the abstinence 
period. Similarly, a two-way ANOVA found only a significant interaction between alcohol 
drinking history and antidepressant treatment on DCX density [F(41,1)=10.3, p=0.003]. As 
shown in Figure 7C, DCX density was reduced in alcohol exposed mice within the vehicle 
condition as compared to water controls (p=0.004, Tukey test).  Also, desipramine blocked 
the reduction in DCX density in alcohol exposed mice (p=0.005, Tukey test).  Taken 
together, these data suggest that abstinence following chronic drinking leads to decreased 
neurogenesis in the dentate gyrus, and that desipramine treatment during abstinence 
prevents this decrease.  
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DISCUSSION 
 
 Clinical studies have noted high degrees of comorbidity between alcoholism and 
depression (Pettinati 2004) and shown that depression that emerges during abstinence 
increases the likelihood of relapse (Hasin et al. 2002).  Although little is known about the 
factors that promote this comorbidity, converging evidence implicates reductions in 
hippocampal neurogenesis as a mechanism that may underlie pathologies associated with 
both alcoholism and depression (Nixon 2006; Warner-Schmidt and Duman 2006).  In this 
study, we show that depression-like behavior is increased during abstinence following 
voluntary alcohol drinking in mice.  This behavioral pathology is associated with a reduction 
in hippocampal neurogenesis and treatment with the antidepressant desipramine restores 
the behavior and measurements of neurogenesis to normal levels.  From these results, we 
propose that reduced hippocampal neurogenesis reflects a neuroadaptive process that 
underlies depression-like behavior that emerges during abstinence following alcohol 
drinking.   
Though alcoholism is commonly associated with human depression, a functional 
relationship between alcohol consumption and depression-like behavior in a preclinical 
model has not been demonstrated previously.  Using a novel mouse behavioral model, this 
study establishes an important link between abstinence following moderate alcohol drinking 
and depression. In mice that voluntarily consumed alcohol for 28 days, increased 
depression-like behavior as measured by the FST was evident 14 days after alcohol was 
removed from the home cage.  Although FST performance showed a trend after 1 day of 
abstinence, this increase in depression-like behavior was not significantly different from 
water controls.  This suggests that the depression-like behavior was dissociated from any 
immediate effects of alcohol exposure or withdrawal.  Further, the absence of withdrawal 
seizures, weight loss, or changes in overall locomotor activity suggests that the voluntary 
alcohol drinking procedure did not produce dependence.  Overall, these results suggest that 
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neuroadaptive changes that occur during protracted abstinence following alcohol drinking 
lead to the emergence of depression-like behavior, even in moderate drinkers. 
In addition to identifying the emergence of depression-like behavior during protracted 
abstinence, the results of this study complement numerous investigations that have 
established a link between alcohol withdrawal and anxiety.  For example, withdrawal from 
alcohol liquid diet, chronic injections, vapor exposure, or consumption from a single drinking 
bottle increase anxiety-like behavior in mice that persists for up to 48-h after alcohol 
exposure (Costall et al. 1988; Joshi et al. 2005; Kliethermes et al. 2004; Prediger et al. 
2006; Sparta et al. 2008).  Similar results have been obtained in rat models showing 
increased anxiety-like behavior during acute and early withdrawal from an alcohol liquid diet 
(Moy et al. 1997; Pandey et al. 1999; Rassnick et al. 1993).  In the present study, we 
observed increased anxiety-like behavior in non-dependent mice 1 day after voluntary 
alcohol drinking as measured by an open-field thigmotaxy assay.  Alcohol exposed mice did 
not differ from water controls when anxiety-like behavior was measured after 2-wks of 
abstinence. Accordingly, other data show that withdrawal from alcohol vapor increases 
anxiety-like behavior in rats during acute (8 hr) withdrawal but the effect dissipates by 2 
weeks (Zhao et al. 2007).  However, studies have reported increased anxiety-like behavior 
at 4 (Rasmussen et al. 2001) and 12 weeks (Zhao et al. 2007) after withdrawal from alcohol 
liquid diet or vapor exposure, respectively.  Together, these and other data (Kliethermes 
2005) suggest that anxiety is a prominent feature of abstinence that may dissipate or cycle 
over time.   Importantly, we found no evidence of increased anxiety-like behavior after 2 
weeks of abstinence when depression-like behavior emerged, which suggests a time-
dependent dissociation of these behavioral pathologies during abstinence.     
A key finding of this preclinical study is that chronic treatment with the antidepressant 
desipramine during abstinence completely blocked the emergence of abstinence-induced 
depression as measured by the FST in mice. Although the FST is most widely used as a 
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behavioral screen for antidepressant efficacy, previous studies have also demonstrated that 
factors associated with human depression including chronic stress, inescapable stress, 
dysregulated monoamine function, and elevated glucocorticoids produce immobility in the 
FST (Hwang et al. 1999; Johnson et al. 2006; Plaznik et al. 1988; Prince and Anisman 
1984). The efficacy of desipramine validates the FST as a measure of depression in the 
present study.  Importantly, the dose of desipramine used had no effect on behavior in the 
FST in water-only control mice.  Furthermore, the prevention of depression-like behavior 
with desipramine, a tricyclic antidepressant, suggests that abstinence following chronic 
drinking may lead to dysregulation of noradrenergic and other monoaminergic systems, and 
that desipramine may prevent this dysregulation.  Additional mechanistic studies are 
required to test this hypothesis.  
While the effectiveness of antidepressants in treating depression is well validated, 
potential efficacy of these compounds in the treatment of alcoholism needs further study. 
There are only a limited number of well-controlled clinical studies on the efficacy of 
antidepressant use for alcoholics (Ostacher 2007). Clinical studies have demonstrated that 
antidepressants are effective in reversing depression comorbid with alcoholism, and have 
shown modest success in preventing relapse (Le Fauve et al. 2004).  As mentioned above, 
depression that occurs during abstinence has been linked to an increased risk of relapse 
(Hasin et al. 2002).  When taken together with the present results, these findings suggest 
that antidepressant treatment that begins concurrently with cessation of drinking may be 
helpful in preventing the emergence of abstinence-related depression in the clinic.  In 
addition, the beneficial effect of antidepressant treatment during abstinence provides further 
support for the conclusion that depression-like behavior may be functionally linked to 
abstinence-induced neuroadaptive changes.  
 The concept of adult neurogenesis has provided a new framework (e.g., the idea of 
structural plasticity) for understanding neuroadaptive changes in the adult brain, which 
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extends prevailing theories that regard changes in synaptic efficacy (Hebb 1949) as a 
solitary mechanism of neuroplasticity (Gage 2002).  Accumulating evidence now indicates 
that NPCs exist in a variety of mammalian brain regions where they give rise to new 
neurons, astrocytes, and oligodendrocytes throughout life (Ming and Song 2005). 
Neurogenesis in the adult brain is a dynamic process that can be influenced by internal and 
external events that also influence behavior (Carlezon et al. 2005; Crews and Nixon 2003; 
Duman et al. 1999; Gage 2002; Henn and Vollmayr 2004; Kempermann 2002; Ming and 
Song 2005). In general, evidence suggests that new neurons in the adult brain contribute to 
synaptic plasticity (Snyder et al. 2001), as well as the general ability of the organism to 
adapt to changing circumstances (Kempermann 2002). Thus, neurogenesis is a structural 
event that may have functional consequences. Indeed, emerging evidence suggests that 
hippocampal neurogenesis may be functionally linked to stress and mood disorders 
(Dranovsky and Hen 2006; Malberg and Blendy 2005; Mirescu and Gould 2006; Warner-
Schmidt and Duman 2006)cf.(Henn and Vollmayr 2004). 
Generation of functional new neurons by neurogenesis requires proliferation, 
differentiation and survival of NPCs.  In this study, we sought to determine if abstinence 
following voluntary alcohol drinking (and depression-like behavior) is associated with 
changes in adult hippocampal neurogenesis.  To address this goal, serial sections of 
hippocampus were immunolabeled for PCNA, which is a cell cycle specific nuclear protein 
belonging to the replication complex that permits DNA synthesis needed for G1 to S 
transition (Krude 1999; Yew et al. 2001) and correlates with the proliferative state of cells 
(Celis et al. 1987).  Results showed that 14 days of abstinence following alcohol drinking 
was associated with a 40% reduction in the number of PCNA positive cells (cells in the 
process of proliferating) in the dentate gyrus as compared to water-only control mice.  
Abstinence from alcohol drinking was also associated with a 40% reduction in 
immunoreactivity for DCX, which is a protein expressed by new cells that are in the process 
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of differentiating into mature neurons.  However, no reductions in PCNA or DCX 
immunoreactivity were observed at 0 or 2 days after alcohol indicating that the reduction in 
proliferating and differentiating NPCs emerged during protracted abstinence.  These results 
indicate that abstinence-induced depression-like behavior in mice is associated with a 
concomitant reduction in hippocampal neurogenesis.  
 In contrast to the effect of protracted abstinence, we found no effect of 28 days of 
voluntary alcohol drinking, or short-term abstinence (2 days), on adult hippocampal 
neurogenesis (Figure 6B).  Several studies have demonstrated that exposure to high doses 
of alcohol has a detrimental effect on adult hippocampal neurogenesis.  For example, 
exposure to alcohol through binge injection or forced liquid diet models in rats produces 
significant decreases in proliferating NPCs and differentiating neurons (He et al. 2005; Nixon 
and Crews 2002).  In mouse models of voluntary alcohol drinking, high dose intake 
(>25g/kg/day) is also associated with a profound decrease (Crews et al. 2004), whereas 
lower dose intake (6g/kg/day) is associated with an increase in NPC proliferation (Aberg et 
al. 2005).  In the present study, we found that 17-18 g/kg/day of voluntary alcohol intake 
produced no change in proliferating or differentiating NPCs in the dentate gyrus in mice.  
Together these studies suggest that alcohol produces dose-dependent effects on 
hippocampal neurogenesis.   
Emerging studies have also shown that exposure to high doses of alcohol via binge 
injection or liquid diet reduces NPC survival in rats (He et al. 2005; Herrera et al. 2003; 
Nixon and Crews 2002).  To determine if voluntary alcohol drinking and/or abstinence is 
associated with changes in NPC survival, mice were injected with BrdU just before the onset 
of 28 days of alcohol drinking, and the number of surviving cells was measured following 2 
or 14 days of abstinence.  Results showed that the number of BrdU positive cells in the 
dentate gyrus of alcohol exposed mice was unchanged following short-term or protracted 
abstinence as compared to water-only controls. Although the overall number of surviving 
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NPCs was unchanged, it is possible that there was a change in the number of surviving cells 
that became neurons rather than glia. However, the data from triple-label 
immunofluorescence experiments, found no difference in the percentage of BrdU positive 
cells that were co-labeled with either GFAP or NeuN in the dentate gyrus of alcohol exposed 
mice as compared to water-only controls. These data indicate that the abstinence-induced 
depression-like behavior in the present study was not associated with changes in the 
survival rate or phenotype of cells born before the onset of drinking.  Thus, alcohol-induced 
changes in the survival of NPCs may require higher doses of alcohol than those that are 
achieved by voluntary drinking in mice.  
Because it is known that factors that precipitate depression, such as stress and 
increased glucocorticoids, decrease hippocampal neurogenesis (Mirescu and Gould 2006) 
and that antidepressants increase hippocampal neurogenesis (Malberg and Blendy 2005; 
Malberg et al. 2000; Santarelli et al. 2003), we sought to determine if antidepressant 
treatment is effective in preventing abstinence-induced impairments in hippocampal 
neurogenesis that occur in parallel with depression-like behavior.  Chronic treatment with 
the antidepressant desipramine during 14 days of abstinence following alcohol drinking 
prevented the decrease in the number of immature neurons, as well as the number of 
proliferating cells in the dentate gyrus. While the decrease in proliferating cells was smaller 
in the second experiment relative to the first, this effect was due to lower raw data control 
values in the second experiment. We hypothesize that decreased proliferation in the control 
animals in the second experiment could be due to the effects of daily injections. It is worth 
noting that 14 days of desipramine administration had no effect on hippocampal 
neurogenesis in water-drinking mice as measured by PCNA and DCX 
immunohistochemistry. These data suggest that chronic desipramine treatment did not 
simply cause an overall increase in neurogenesis, but rather prevented abstinence-induced 
decreases in hippocampal neurogenesis. 
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The concomitant increase in DCX and PCNA immunoreactivity suggests that 
blockade of abstinence-induced depression-like behavior by desipramine may have been 
mediated by changes in multiple phases of hippocampal neurogenesis.  Evidence indicates 
that NPCs express PCNA during and up to 4 days after the S phase of the cell cycle 
(Mandyam et al. 2007); however, DCX expression peaks in the dentate gyrus between 1 
and 21 days after the S phase when NPC differentiation is occurring (Brown et al. 2003).  
Immunohistochemical studies of PCNA and DCX performed on a single day, therefore, are 
likely labeling mostly distinct populations of new cells.  Thus, it is not clear from the present 
study if antidepressant treatment specifically protected against the abstinence-induced 
reduction in NPC proliferation or enhanced survival of post-proliferative cells born during the 
abstinence phase, either or both of which would lead to an increase in new neurons.   
Alternatively, it is also plausible that protection against the abstinence-induced reduction in 
the number of new neurons by desipramine may have been conferred by a compensatory 
burst in NPC proliferation, which has been reported to occur 7 days after withdrawal from 
binge injection of alcohol (Nixon and Crews 2004).  These potential alternatives could be 
addressed in future studies that further elucidate the timecourse of changes in various 
phases of neurogenesis during abstinence from alcohol drinking.  In either case, it appears 
from the present study that chronic antidepressant treatment protects against abstinence-
induced reductions in both NPC proliferation and development of new neurons. 
Although there is no single neurobiological mechanism that accounts for the behavioral 
pathologies associated with alcoholism or depression, converging evidence suggests that 
alcoholism and depression (and perhaps their co-occurrence) may share common molecular 
mechanisms of action. For example, chronic alcohol exposure reduces cAMP response 
element-binding protein (CREB) activity in the dentate gyrus (Bison and Crews 2003).  
Reductions in CREB activity and function can occur during acute and protracted alcohol 
withdrawal and are associated with negative mood states, such as anxiety (Pandey 2003)). 
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By contrast, a variety of antidepressant drugs increase levels of CREB mRNA in the 
hippocampus (Nibuya et al. 1996). Viral over-expression of CREB in the dentate gyrus of 
the hippocampus also results in less depression-like behavior in both the FST and learned 
helplessness tests (Chen et al. 2001).  Accordingly, alcohol withdrawal is associated with 
reduced expression of CREB-target genes including brain-derived neurotrophic factor 
(BDNF) in the dentate gyrus (Tapia-Arancibia et al. 2001) whereas several different 
antidepressant drugs, including desipramine which was used in the present study, increase 
BDNF mRNA in the hippocampus (Nibuya et al. 1995).  Moreover, chronic alcohol reduces 
hippocampal neurogenesis (Nixon and Crews 2002) but the behavioral effects of 
antidepressant medications may require hippocampal (Santarelli et al. 2003).  These and 
other findings have led to emerging theories that implicate a CREB – BDNF – neurogenesis 
pathway in both the etiology of depression and antidepressant efficacy (Duman et al. 2001; 
Malberg et al. 2000; Thomas and Peterson 2003). Overall, CREB and BDNF activity in the 
dentate gyrus appear to be important mediators of antidepressant efficacy and raise the 
hypothesis that decreases in p-CREB, such as those that occur after chronic alcohol, have 
the potential to induce behavioral despair and reductions in neurogenesis as seen in the 
present study.   
Several limitations to the present study should be discussed.  First, although the data 
presented in this study suggest that depression-like behavior and related neuroadaptations 
emerge during abstinence following chronic drinking, it is worth mentioning that no single 
animal model of depression is sufficient to characterize the human condition of depression. 
In these experiments, we sought to characterize changes in affective behavior at a single 
time point during abstinence, which limited the number and type of behavioral measures we 
were able to conduct. Thus, it will be important in future studies to utilize other validated 
rodent behavioral tests of anxiety- and depression-like behavior to confirm and extend the 
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present results.  Second, it is worth noting that a 300 mg/kg dose of BrdU was chosen to 
examine NPC survival based on a published method (Cameron and McKay 2001), which 
suggested that this dose labels all cells in the S phase in the rat.  However, a recent 
publication (Mandyam et al. 2007) has demonstrated that 150 mg/kg is sufficient to label all 
cells in the S phase in the mouse. Thus, we cannot rule out the possibility that our BrdU 
injection regimen caused toxicity to dividing cells, especially in combination with subsequent 
alcohol consumption; however, as no differences were found in the number of BrdU-labeled 
cells between any groups, we feel this probably did not contribute significantly to our results.  
Finally, our results showing that desipramine did not alter FST performance in or 
neurogenesis in control mice are somewhat surprising.  Another study demonstrated that 
chronic desipramine treatment increases neurogenesis and decreases depression-like 
behavior in control mice; however, this study used utilized twice-daily administration of 12.5 
mg/kg desipramine (Gur et al. 2007), indicating that a higher dose may have produced 
changes in our control animals. Additionally, while acute desipramine treatment has been 
shown to reduce immobility in the FST (Lucki et al. 2001), we did not administer desipramine 
on the day of the test. Our results are similar to those found by MacQueen et al., (2003), 
showing that that 14 days administration of desipramine at the same dose used in the 
current study (15 mg/kg) and not administered on the day of testing reduced immobility in 
the FST in mice in which depression had been induced, but not in control mice.   
In conclusion, alcoholism and depression are two devastating disorders that 
commonly co-occur. Emerging evidence indicates that alcohol has detrimental effects on 
molecular pathways that may be involved in the pathophysiology of depression. Important 
clinical evidence indicates that depression that emerges during abstinence has a greater 
negative impact on relapse rates than pre-existing depression. Preclinical studies on this 
topic are lacking. To address this need, we have developed and validated a novel model of 
alcohol drinking-induced depression-like behavior in mice. The data presented here lend 
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further support to the hypothesis that hippocampal neurogenesis is related to depression, as 
well as antidepressant efficacy.  We show that abstinence following chronic alcohol drinking 
leads to a decrease in adult hippocampal neurogenesis at a time when depression-like 
behavior is also evident.  Antidepressant treatment during abstinence prevents both the 
decrease in new neurons and the depression-like behavior, suggesting a mechanistic link.  
Given that new neurons constitute 6% of the total granule cells in the hippocampus, 
neurogenesis is crucial for hippocampal function (Cameron and McKay 2001) and of 
potential importance to the etiology and treatment of alcoholism and co-morbid depression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER III: THE EFFECTS OF DESIPRAMINE ADMINISTRATION DURING 
ABSTINENCE FOLLOWING ALCOHOL DRINKING ON CREB EXPRESSION AND 
ACTIVATION  
 
INTRODUCTION 
Alcoholism and depression are two of the most costly and widespread neuropsychiatric 
disorders worldwide. In the United States, the prevalence of a lifetime history of depression 
in alcohol dependent individuals has been reported to be about 42% (Miller et al. 1996; 
Schuckit et al. 1997b)  but comorbidity ranges from 5% to as high as 80% have been noted 
in some studies (Pettinati 2004). When alcoholism and depression co-occur, relapse to 
alcohol use is more likely and remission from depression is less likely (Greenfield et al. 
1998; Mueller et al. 1994) Importantly, depression that occurs during abstinence increases 
the likelihood of relapse in alcoholics, whereas prior-onset depression is not related to 
relapse (Hasin et al. 2002). Abstinence-related depression is thought to increase the chance 
of relapse because drinking may help people cope with negative emotions (Carpenter and 
Hasin 1998; Hasin and Grant 2002). 
Converging evidence suggests that alcoholism and depression (and perhaps their co-
occurrence) may share common molecular mechanisms of action.  Our previous work 
indicates a direct mechanism by which abstinence following alcohol drinking leads to 
depression-like behavior, and suggests that alterations in neurogenesis could represent 
such a mechanism, though no causal relationship has been demonstrated (Stevenson et 
al.). Recent studies show that alcohol and antidepressant drugs produce opposite changes 
in second messenger systems in the hippocampus that can alter activity of transcription 
factors such as cAMP response element-binding protein (CREB). CREB activity influences 
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neurotrophic pathways and, depending on the direction of change, can increase or decrease 
hippocampal neurogenesis (D'Sa and Duman; Malberg and Blendy 2005). Interestingly, 
decreased CREB function in the nucleus accumbens has been shown to have an 
antidepressant effect (Pliakas et al. 2001), indicating that CREB may have regionally distinct 
effects on behavior. We hypothesized that CREB activation may be a molecular mechanism 
by which desipramine prevents changes in depression-like behavior and neurogensis 
produced by abstinence from chronic alcohol drinking.  
The transcriptional regulator cAMP-response-element-binding protein (CREB) is widely 
and abundantly expressed in the mammalian brain.  Transcription factors such as CREB 
transduce changes in membrane receptor activity and signaling pathways into alterations in 
gene expression. By regulating changes in gene expression, CREB activation can lead to 
long-term changes in the function of single neurons, brain regions, and neural circuits. 
Indeed, many of the plasticity-related neural events associated with addiction (Nestler 2004) 
and depression (Duman et al. 1997) are thought to involve changes in CREB activity. 
CREB-dependent transcription is primarily regulated by kinase-induced phosphorylation of 
CREB at serine residue 133 (Ser-133) (Johannessen et al. 2004). Changes in the level of p-
CREB can in turn alter expression of any number of CREB target genes (i.e., genes with 
CRE sites in their promoter regions). CREB target genes are found in a variety of systems 
including: metabolism, transcription (e.g., EGR-1, c-FOS, JUND), neuropeptides (CRF, 
galanin, NPY, vasopressin), and growth factors (BDNF, TNFalpha) (Mayr and Montminy 
2001). Identifying specific conditions that alter CREB activation has fundamental importance 
for understanding a variety of neural functions and disorders including alcoholism and 
depression. 
Accumulating evidence also suggests that CREB (and its target genes) regulates alcohol 
dependence and withdrawal and may underlie anxiety associated with alcohol withdrawal 
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(Pandey 2003). Studies have shown that CREB activation is altered due to chronic and 
acute alcohol exposure. Furthermore, CREB activation in the amygdala, nucleus 
accumbens, and cortical structures is altered during the first 72 hours of withdrawal from 
chronic alcohol drinking. (Li et al. 2003; Misra et al. 2001; Pandey et al. 1999). Interestingly, 
CREB haplodeficient mice have a higher preference for ethanol, resulting in greater ethanol 
consumption in a two-bottle choice method of drinking (Pandey et al. 2004).  
Our laboratory has developed a mouse model in which depression-like behavior 
emerges after two weeks of abstinence following chronic voluntary alcohol drinking 
(Stevenson et al.). We have shown that the emergence of depression-like behavior occurs 
in parallel with decreases in both proliferating and differentiating hippocampal neurons. In 
addition, this study showed that administration of the antidepressant desipramine for the 
duration of the abstinence period (14 days) completely prevented the increase in 
depression-like behavior, as well as the decrease in hippocampal neurogenesis.   
In the current study, we examined the effects of abstinence following chronic alcohol on 
CREB activation. In addition, we studied the brains of mice that received chronic 
desipramine treatment during the abstinence period in order to investigate the role of CREB 
activation in the prevention of abstinence-induced depression-like behavior and decreases 
in neurogenesis.  The nucleus accumbens, amygdala, and hippocampus are all brain 
regions that are implicated in emotionality as well as addiction; therefore we examined 
changes in CREB activation in the core and shell of the nucleus accumbens and the central 
and basolateral amygdala, in addition to the denate gyrus, CA1, and CA3 regions of the 
hippocampus.  
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METHODS 
Animals 
 Adult male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were singly 
housed in standard Plexiglas cages with Purina Rodent Chow and fluid always available. 
Mice were 9 weeks old at the start of all experiments. The vivarium was maintained at 27ºC 
on a reverse 12:12 light-dark cycle (lights on at 22:00). Animals were under continuous care 
and monitoring by veterinary staff from the Division of Laboratory Animal Medicine at UNC-
Chapel Hill, and all procedures were also carried out in accordance with the NIH Guide to 
Care and Use of Laboratory Animals (National Research Council, 1996) and institutional 
guidelines.  
 Animals were handled and treated as previously reported (Stevenson et al.). Mice 
were allowed 7 days to adapt to handling and the laboratory environment.  Mice were 
randomly assigned to the following treatment conditions:  two groups of alcohol-drinking 
mice voluntarily consumed alcohol or water for 28 days using a two-bottle drinking 
procedure (see below); one group of water-only controls had access to two bottles of water 
for 28 days.  Alcohol-drinking mice then received injections of either vehicle (n=12, saline) or 
desipramine (n=12, once per day, 15 mg/kg, I.P.) during a 14 day abstinence period.  Water-
only control mice received daily injections of either vehicle (n=12) or desipramine (n=12) in 
parallel to the alcohol-abstinent mice. Water-only mice that received vehicle injections 
served as a control for alcohol exposure and injection stress.  After the 14th day of 
abstinence, animals were sacrificed and their brains were removed for immunohistochemical 
studies. 
Two-Bottle Drinking Procedure 
 During the one week period of acclimation and handling, water was the only fluid 
available. All fluids were presented in the home cage via 50mL plastic centrifuge bottles with 
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stainless steel sipper tubes. Alcohol-drinking mice were then given access to one bottle of 
water and one bottle of alcohol (10%v/v) as previously described (Hodge et al. 1999). 
Animals were weighed and the fluid levels in the bottles were monitored to the nearest 0.5 
mL at 24-hr intervals to determine daily fluid intake (mL and g/kg). The position (left-right) of 
the alcohol and water bottle was changed each day to control for side preferences. Mice 
were given access to alcohol for 28 days. Control animals had access to two bottles of water 
for the same duration (28 days). 
Tissue Fixation and Sectioning  
Animals were deeply anesthetized with pentobarbital (60 mg/kg, 10 mL/kg, IP) and 
perfused transcardially with 0.1 M phosphate buffered saline (PBS) followed by 4% 
paraformaldehyde. The brains were removed from the skull and placed in the same fixative 
solution for at least 24-hr before being washed with PBS and sliced on a Leica VT 1000S 
vibrating microtome into 40 µm sections. The free-floating sections were stored in 
cryoprotectant at -20°C until immunohistochemistry was performed.  
Immunohistochemistry 
Tissue was washed in PBS, and then treated with 0.6% hydrogen peroxide to block 
endogenous peroxidase activity. Tissue was incubated for 1-hr in a blocking solution (3% 
horse serum, 0.1% Triton-X, 0.1M PBS) before incubation in the primary antibody. Sections 
were incubated in the anti-phospho CREB antibody (Upstate Biotechnology Inc, Lake 
Placid, NY; dilution 1:2500) overnight at 4°C or in the anti-CREB antibody (Cell Signaling 
Technology, Danvers, MA; dilution: 1:4000) for 48 hrs at 4°C. The following day, sections 
were washed in PBS and incubated in secondary antibody for one hour (Dako EnVision Kit, 
Dako).  Immunoreactivity was detected with nickel-enhanced diaminobenzidine (Dako 
EnVision Kit) as a chromagen.  Sections stained for pCREB were counterstained with 
toluidine blue. All sections were then mounted onto slides, dried and coverslipped with 
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Cytoseal.  For consistency of staining across subjects, brain tissue from all groups was 
processed simultaneously. 
Immunoreactivity was quantified using Bioquant image analysis software (Bioquant Nova 
Advanced Image Analysis; R&M Biometric, Nashville, TN).  The image was background 
corrected and normalized to preset light levels to ensure consistent data collection.  Pixel 
count measurements were calculated from a brain region and divided by the area of the 
region and expressed as pixels/mm2.  All data was acquired by a researcher blind to group 
condition from every sixth section of a whole brain and averaged to obtain a single value per 
subject. 
RESULTS  
CREB expression and or activation has been shown to be involved in addiction, 
depression, antidepressant activity, and neurogenesis (Chen et al. 2001; Gur et al. 2007; 
Malberg and Blendy 2005; Nestler 2004; Pandey 2004; Tardito et al. 2006; Thome et al. 
2000).  In the current study, we performed immunohistochemical analyses of CREB and 
phospho-CREB in the brains of mice that drank alcohol vs. water or water only for four 
weeks, followed by two weeks of abstinence. During the abstinence period, mice received 
either desipramine or vehicle treatment.  
Two-bottle choice drinking. A two-way repeated measures ANOVA revealed that 
mouse weight significantly increased over the six week period [F(5,110)=118.161, p<0.001], 
but that the weights of alcohol and water drinking mice were not different. A two-way 
repeated measures ANOVA comparing total fluid intake in alcohol versus water drinking 
animals over the six week experiment showed that, during the four weeks of two-bottle 
choice drinking, alcohol-drinking mice consume an significantly less fluid per day than water-
drinking mice [F(1,108)=15.397, p<0.001]; however the difference in means is 0.451 mL. 
Additionally, there was a main effect of time during the experiment, with fluid consumption 
during the final two weeks (when only one bottle was present on the cages) being 
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significantly lower than the first four weeks (when two bottles are present on each cage) 
[F(5,108)=3.566, p=0.005], again with a difference of means of less than 0.5 mL. We believe 
this decrease in fluid intake over the final two weeks is probably due to smaller error (water 
dripping from the bottle) associated with reading fluid levels on one bottle instead of two.  
CREB activation in the hippocampus. Evidence suggests that CREB activity in the 
hippocampus may be involved in depression, antidepressant activity, and neurogensis 
(Carlezon et al. 2005; Chen et al. 2001; Gur et al. 2007; Malberg and Blendy 2005; 
Nakagawa et al. 2002b; Nibuya et al. 1996; Thome et al. 2000). We measured pCREB 
immunoreactivity (IR) in the dentate gyrus, CA1, and CA3 regions of the hippocampus to 
determine if alcohol abstinence or desipramine treatment produced changes in CREB 
activation. A two way ANOVA revealed that both alcohol [F(1,31)=7.1, p=0.012] and 
desipramine [F(1,31)=10.0, p=0.003] significantly increased pCREB IR in the dentate gyrus. 
Additionally, there was a significant interaction between alcohol drinking and desipramine 
treatment [F(1,31)=4.62, p=0.039]. Post-hoc multiple comparisons demonstrated that 
desipramine treatment significantly increased pCREB IR in the dentate gyrus in W+D mice 
compared to W+S mice (p<0.001, Tukey test), and in E+S mice compared to W+S mice 
(p=0.003, Tukey test). These data indicate that both abstinence following alcohol drinking 
and treatment with the antidepressant desipramine promote CREB activity in the dentate 
gyrus. Desitometric analysis within the CA1 region of the hippocampus showed that neither 
abstinence following alcohol drinking nor desipramine treatment produced significant 
changes in pCREB IR.  In contrast to the CA1, two way ANOVA of pCREB IR in the CA3 
region of the hippocampus revealed a main effect of abstinence from alcohol drinking [F(1, 
31)=4.205, p=0.049], as well as an significant interaction between alcohol drinking history 
and desipramine treatment [F(1, 31)=4.216, p=0.049]. Post-hoc multiple comparisons 
demonstrated a significant decrease in CREB activation in E+S mice compared to W+S 
mice (p=0.008, Tukey test), and compared to E+D mice (p=0.018, Tukey test), 
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demonstrating that desipramine treatment completely blocked or reversed abstinence-
induced decreases in pCREB in the CA3. 
CREB expression in the hippocampus. We examined expression of CREB using 
anti-CREB immunohistochemistry in dentate gyrus, CA1, and CA3 regions of the 
hippocampus. In the dentate gyrus, abstinence following alcohol drinking is associated with 
a small increase in CREB expression [F(25,1)=4.431, p=0.046]. This is in accordance with 
the parallel abstinence-induced increases in CREB activation in the dentate gyrus. While 
CREB activity in the CA1 was unchanged by abstinence following alcohol drinking and 
desipramine, this region did show significant changes in CREB expression. A two-way 
ANOVA revealed that desipramine caused a significant increase in CREB expression in the 
CA1 [F(25,1)=9.735, p=0.005], and a significant interaction between abstinence following 
alcohol drinking and desipramine treatment was also found [F(25,1)=17.706, p<0.001]. Post-
hoc pairwise comparisons revealed that W+D mice had significantly higher levels of CREB 
expression compared to W+S mice (p<0.001, Tukey test), and E+S mice showed increased 
CREB expression compared to W+S mice (p<0.001, Tukey test).  These data demonstrate 
that desipramine treatment increases CREB expression in the CA1, but does not cause a 
further increase in CREB expression in alcohol-abstinent animals. In the CA3 region of the 
hippocampus, abstinence following alcohol drinking was associated with a significant 
decrease in CREB expression [F(23,1)=5.776, p=0.025]. A two-way ANOVA also found an 
interaction between abstinence from alcohol drinking and treatment with the antidepressant 
desipramine [F(23,1)=7.069, p=0.014]. Post-hoc pairwise multiple comparisons revealed 
that a large decrease in CREB expression in E+S mice compared to W+S mice (p=0.003, 
Tukey test), and a large increase in E+D mice compared to E+S mice (p=0.005, Tukey test), 
indicating that desipramine treatment completely prevented alcohol-abstinence induced 
decreases in CREB expression in the CA3. due to alcohol abstinence was completely 
prevented by desipramine treatment These data demonstrate that CREB expression and 
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CREB activation in the CA3 are altered in a parallel manner in response to alcohol 
abstinence and desipramine treatment.  
CREB activation in the nucleus accumbens. Activity of the transcription factor 
CREB in the nucleus accumbens has been implicated in drug addiction, alcohol exposure, 
and depression-like behavior (Carlezon, 2005; Li, 2003; Misra, 2001; Nestler, 2004; Pandey, 
2004; Pliakas, 2001; Yang, 1998). In the present study we examined the effects of two 
weeks of abstinence following alcohol drinking on CREB activation in the nucleus 
accumbens core and shell. Additionally, we investigated if CREB activation is altered in the 
nucleus accumbens in response to desipramine treatment during the abstinence period. 
Both the core and the shell of the nucleus accumbens showed similar responses. 
Abstinence following alcohol drinking was not associated with a change in pCREB IR in the 
core [F(1,30)=2.221, p=0.147] or the shell  [F(1,30)=0.0359, p=0.851] of the accumbens. 
Desipramine treatment, however, resulted in a significant overall increase in pCREB IR in 
both the core [F(1,30)=5.096, p=0.031] and the shell [F(1,30)=8.150, p=0.008]. These data 
suggest that two weeks of abstinence following chronic alcohol drinking is not associated 
with changes in CREB activity in the nucleus accumbens, but that desipramine treatment, 
regardless of drinking history, significantly upregulates CREB activity in the accumbens.  
CREB expression in the nucleus accumbens.  No changes were evident in CREB 
expression in the core or the shell of the nucleus accumbens in any group of animals.  
CREB activation in the amygdala. CREB has been shown to be activated in the 
amygdala in response to alcohol and alcohol withdrawal (Pandey 2003; Pandey et al. 2003; 
Pandey et al. 2004; Pandey et al. 1999).  In the current study, we sought to determine if 
CREB activity in the central (CeA)and basolateral (BLA) nuclei of the amygdala was altered 
in response to two weeks of abstinence following chronic alcohol drinking, as well as if 
desipramine treatment during the abstinence period affected CREB activity in these 
amygdalar nuclei. The CeA showed results similar to the nucleus accumbens. Desipramine 
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treatment during the abstinence period was associated with a significant overall increase in 
pCREB IR [F(1,31)=5.07, p=0.032]. Two weeks of abstinence from alcohol drinking did not 
produce any change in pCREB IR in the CeA. No changes in pCREB IR were evident in the 
BLA as a result of abstinence from alcohol drinking or desipramine treatment during the 
abstinence period. These data indicate that desipramine upregulates CREB activity in the 
CeA, but has no effect on CREB activity in the BLA. 
CREB expression in the amygdala.  Lastly, we examined CREB expression in the 
CeA and BLA.  The CeA showed a significant increase in CREB activation in response to 
desipramine treatment, but no change in CREB expression; whereas the BLA showed no 
change in CREB activation, but did show a significant increase in CREB expression in 
response to desipramine treatment (F(28,1)=5.544, p=0.026). Abstinence following alcohol 
drinking was not associated with changes in CREB expression in either nucleus of the 
amygdala.  
 
DISCUSSION 
 
In the current study we demonstrate that abstinence following chronic voluntary 
alcohol drinking is associated with changes in CREB activation and expression in the 
hippocampus. Additionally, we show that desipramine, when administered for two weeks 
following chronic alcohol drinking or water drinking is also associated with changes in CREB 
activity and expression in the hippocampus and amygdala. CREB activation, but not 
expression in the nucleus accumbens is altered by chronic desipramine treatment in animals 
with or without a history of alcohol drinking. Together, these data suggest that CREB-
dependent transcription is affected by both abstinence following alcohol drinking and 
desipramine treatment, and that these effects are brain region specific.  
CAMP-response-element-binding protein is a transcription factor that, when 
phosphorylated at serine 133, is activated and can bind to CRE sites in the promoter region 
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of many genes. The binding of CREB is one of the requirements for activation of 
transcription of CRE site-containing genes. Phosphorylation of CREB can be accomplished 
via several kinases that are downstream of G-protein-coupled receptors, receptor tyrosine 
kinases, and calcium-dependent signaling cascades, all of which are implicated in alcohol 
addiction and depression (Mayr and Montminy 2001; Nestler 2004; Pandey 2004). CREB 
signaling, therefore, may represent a final common mechanism underlying both of these 
diseases. Abstinence following alcohol drinking has been shown to produce depression-like 
behavior, and this depression is prevented by antidepressant treatment (Stevenson et al.). 
We, therefore, wanted to determine the effects of abstinence following chronic alcohol 
drinking and antidepressant treatment on CREB signaling in brain regions known to be 
involved in alcoholism and mood.  
 The transcription factor CREB has been suggested to play an important role in the 
behavioral efficacy of antidepressants. Changes in CREB expression and activation are 
seen only after chronic, but not acute, administration of antidepressants (Nibuya et al.; 
Thome et al.). CREB, therefore, could be a mechanism underlying the delayed behavioral 
efficacy of antidepressants.  Additionally, virally mediated expression of CREB of in the 
hippocampus of rats has been shown to have an antidepressant effect (Chen et al.). Other 
studies, however, have demonstrated that the behavioral effects of chronic antidepressant 
treatment may occur in a CREB-independent manner and be enhanced by CREB down-
regulation (Conti et al.; Gur et al.). The role of CREB in the therapeutic efficacy of 
antidepressant drugs, therefore, remains unclear.  
The role of CREB in the hippocampus has been the target of many studies on 
antidepressant efficacy (Blom et al.; Gur et al.; Nibuya et al.; Thome et al.; Tiraboschi et al.); 
therefore, a primary goal of this study was to evaluate the role of CREB activation and 
expression in the hippocampus in our study of antidepressant treatment during alcohol 
abstinence. We found subregionally distinct changes in both activation and expression of 
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CREB in the hippocampus, as measured by pCREB and CREB IR, respectively. Two weeks 
of abstinence following chronic alcohol drinking was associated with increased pCREB IR in 
the dentate gyrus, and increased CREB IR in the CA1. We were surprised to see increases 
in CREB and pCREB IR in the CA1 and dentate after two weeks of abstinence from alcohol 
drinking, as these data suggest that CREB expression and activation are higher in the 
hippocampus, however our previous data demonstrate that depression-like behavior 
emerges during this abstinence period (Stevenson et al.). These increases were also not 
altered by desipramine treatment, which we have shown prevents abstinence-induced 
depression-like behavior. These data are consistent with the finding that CREB-deficient 
mice show a baseline antidepressant phenotype and are less sensitive to desipramine (Gur 
et al.). Chronic desipramine administration increased pCREB IR in the dentate gyrus, and 
CREB IR in the CA1 of water drinking animals only. In contrast, we found a large decrease 
in CREB and pCREB IR in the CA3 due to abstinence, and desipramine treatment 
completely prevented these changes, while having no effect on CREB or pCREB IR the CA3 
of water drinking animals. These changes in CREB perfectly parallel the behavioral changes 
we have previously reported using this model of alcohol-related depression-like behavior 
(Stevenson et al.); therefore, alterations in CREB expression and activation indicated by 
decreased CREB and pCREB IR in the CA3 may represent an anatomically specific 
molecular mechanism underlying depression-like behavior that emerges during abstinence 
following chronic alcohol drinking, and a target of desipramine treatment. The subregional 
dissociation of the changes observed in CREB may explain some of the inconsistent 
findings regarding the role of CREB in the hippocampus.  
Several studies have demonstrated that antidepressants of different classes promote 
hippocampal neurogenesis (Malberg and Blendy 2005). Researchers have also postulated 
that the beneficial effects of antidepressants require hippocampal neurogenesis (Malberg 
and Schechter 2005; Santarelli et al.). Treatment with antidepressants increases CREB and 
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neurogenesis in a parallel fashion (Malberg and Blendy 2005), and mice with a dominant 
negative form of CREB in the hippocampus show decreased neurogenesis (Nakagawa et 
al.). Furthermore, pCREB is expressed in new neurons (Nakagawa et al.). Because mice 
show a significant decrease in neurogenesis after two weeks of abstinence from alcohol 
drinking (Stevenson et al.), we hypothesized that we would also see an abstinence-induced 
decrease in CREB or pCREB IR in the dentate gyrus. The fact that we observed an increase 
in CREB IR in the dentate after two weeks of abstinence, a treatment shown to reduce 
neurogenesis, again supports the finding that CREB deficient mice have increased basal 
levels of hippocampal neurogenesis (Gur et al.).   
 Desipramine treatment and abstinence following chronic alcohol drinking have 
opposing effects on CREB expression and activation in the CA3 subregion of the 
hippocampus in the current study. In fact, the CA3 is unique among the brain regions we 
have examined in showing an interaction between abstinence and desipramine treatment on 
changes in CREB.  This finding suggests that CREB signaling in the CA3 may play an 
important role in mediating the emergence of depression-like behavior during alcohol 
abstinence (Stevenson et al.). The CA3 subregion of the hippocampus is known to be 
especially sensitive to stress and high levels of glucocorticoids (Arbel et al.; De Kloet et al.; 
Fuchs et al.; Magarinos et al.). Pyramidal cells in the CA3 show dendritic retraction in 
response to high levels of corticosterone (McEwen 1999), and it has been suggested that 
this dendritic remodeling may underlie increased vulnerability of the brain following chronic 
stressors (McEwen 2001).  Interestingly, increased brain-derived neurotrophic factor 
(BDNF), a target gene of CREB, has been shown to be upregulated in the CA3 of rats that 
are resilient to chronic mild stress (Bergstrom et al.). Taken together, these data suggest 
that CREB-dependent transcription of trophic factors such as BDNF may protect against 
stress-induced structural changes in the CA3. Furthermore, CREB-dependent transcription 
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in the CA3 may protect against the vulnerabilities created by abstinence following chronic 
alcohol drinking.  
 Because the amygdala is known to be involved in stress, emotional reactivity, and 
addictive behavior, we investigated CREB expression and activation in this region by 
measuring CREB and pCREB IR. CREB, a molecular mechanism known to be involved in 
long-term potentiation, has been linked to consolidation of emotional memory in the 
amygdala (Rodrigues et al.). The amygdala has been shown to be involved in allostasis and 
negative affective states associated with the development of alcoholism has been 
demonstrated (Koob 2003; Pandey 2004). In particular, CREB is decreased in the amygdala 
following 24 hours of withdrawal from chronic alcohol drinking, when anxiety-like behavior is 
increased (Pandey et al. 2001a; Pandey et al. 2003). Furthermore, inhibition of CREB 
phosphorylation in the amygdala is anxiogenic and increases preference for alcohol 
(Pandey et al. 2003).   
We examined CREB IR and pCREB IR in the basolateral and central nuclei of the 
amygdala following desipramine or vehicle treatment during abstinence from alcohol 
drinking. In general, it is thought the basolateral nucleus of the amygdala receives 
information from sensory and association cortices. The basolateral nucleus has projections 
to the central nucleus, as well as the nucleus accumbens among other targets. The central 
nucleus is considered to be the major output region of the amygdala (LeDoux 2007). Two 
weeks of abstinence following chronic alcohol drinking did not produce changes in CREB or 
pCREB IR in either nucleus of the amygdala. As this abstinence period has been shown to 
promote depression-like behavior (Stevenson et al.), these data suggest that this particular 
negative affective state is not associated with decreased CREB in the amygdala. 
Desipramine treatment, however, increased pCREB IR in the central nucleus, and CREB IR 
in the basolateral nucleus, suggesting that a treatment that promotes positive affective 
states also increases CREB in the amygdala. While increased phosphorylation of CREB, as 
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in the central nucleus following desipramine treatment, indicates an upregulation of CREB-
dependent transcription, increased CREB expression in the absence of increased CREB 
activation, as in the basolateral nucleus is more difficult to interpret. One possible 
interpretation is that increased expression of CREB is a compensatory response to 
decreases in one of the CREB signaling pathways that could have occurred earlier in 
abstinence or during the alcohol drinking phase of the experiment. Indeed, previous work in 
rats does supports the idea that CREB activity is downregulated in the amygdala due to 
chronic alcohol drinking and short-term withdrawal (Pandey 2004; Pandey et al. 2001a; 
Pandey et al. 2001b; Pandey et al.). One limitation of this study is that we were only able to 
measure changes in CREB at the end of the two-week abstinence period. Further studies of 
the effects of chronic voluntary alcohol drinking and short-term withdrawal in the mouse are 
warranted.  
 The nucleus accumbens plays an important role in reward and addiction. Most drugs 
of abuse, including alcohol, cause dopamine release in the nucleus accumbens, and this 
neurotransmission has been shown to be crucial for the rewarding effects of drugs of abuse 
(Di Chiara and Bassareo 2007). Furthermore, dopaminergic, GABAergic, and 
neuropeptidergic signaling the nucleus accumbens have all been shown to influence alcohol 
reinforcement (Hodge and Alken 1996; Hodge et al.; Olive et al.; Slawecki et al.). CREB is 
downstream of multiple neurotransmission pathways and may represent a convergent 
mechanism for altering gene transcription (Pandey 2004). Decreased CREB activity in the 
nucleus accumbens is associated with increased alcohol drinking, while increased CREB is 
associated with reduced rewarding properties of drugs of abuse (Carlezon et al.; Misra et al. 
2001). Moreover, over-expression of CREB in the nucleus accumbens has been shown to 
have a pro-depressant effect (Pliakas et al.), indicating that CREB signaling in the nucleus 
accumbens may play a role in positive and negative affective states, as well as drug abuse 
and addiction.  
 50
In the present study, we investigated possible changes in CREB in the nucleus 
accumbens after two-weeks of abstinence following alcohol drinking with or without 
desipramine treatment during the abstinence period.  Similar to the amygdala, abstinence 
following alcohol drinking was not associated with changes in CREB or pCREB IR in the 
nucleus accumbens. Desipramine treatment, however, was associated with increased 
pCREB IR in the nucleus accumbens, regardless of the animal’s drinking history. These 
data indicate that chronic desipramine treatment increases CREB phosphorylation in the 
nucleus accumbens. Based on the studies demonstrating that CREB overexpression in the 
nucleus accumbens increases depression-like behavior (Pliakas et al. 2001), we expected 
to see decreased CREB or CREB activation in the nucleus accumbens following 
desipramine treatment. The fact that we did not may suggest dissociation between the role 
of CREB signaling in the behavioral response to or coping strategy for an acute stressor (eg. 
FST) and the role of CREB signaling in mediating the effects of chronic antidepressant 
treatment.  
Abstinence following alcohol drinking and antidepressant treatments have opposing 
effects of depression-like behavior (Stevenson et al.). We, therefore, sought to examine the 
role of CREB in mediating these opposing effects. The current study indicates that CREB 
expression and activation are altered both by abstinence following chronic alcohol drinking 
and by desipramine during the abstinence period. Our data suggest that the CA3 subregion 
of the hippocampus may be a brain region that is vulnerable to abstinence following alcohol 
drinking, and a target of antidepressant drugs. CREB, particularly in the CA3 subregion in 
the hippocampus, may represent a common mechanism underlying abstinence- and 
antidepressant-related neuroadaptations.  
CREB expression and activation are altered in a regionally specific manner in 
response to abstinence following alcohol drinking and treatment with the antidepressant 
desipramine. In our studies, the effects of abstinence following alcohol drinking on CREB 
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are limited to the hippocampus, where pCREB IR is increased in the dentate gyrus, CREB 
IR is increased in the CA1, and both CREB and pCREB IR are robustly decreased in the 
CA3. Desipramine treatment, on the other hand, caused increases or prevented decreases 
in CREB or pCREB IR in all three regions that we examined. These data would indicate that 
desipramine has an overall effect of increasing CREB-related signaling mechanisms. 
Importantly, desipramine treatment completely prevented the most significant decrease in 
CREB expression and activation due to abstinence, which occurred in the CA3 subregion of 
the hippocampus. Because of the central position of CREB as a downstream effector 
molecule of several signaling pathways, this molecule may represent a convergence point 
for the opposing effects of alcoholism and antidepressants treatments.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER IV: ASSESSMENT OF THE HPA AXIS DURING ABSTINENCE FOLLOWING 
CHRONIC ALCOHOL DRINKING 
 
INTRODUCTION 
  Alcoholism is a disease that is characterized by periods of abstinence followed by 
relapse. The counter-adaptations that occur during abstinence as a result of chronic alcohol 
drinking and cessation of chronic alcohol drinking may enhance one’s vulnerability to 
relapse (Ahmed and Koob 1998; Koob and Le Moal 2008).  Among the counter-adaptations 
known to occur are alterations of the hypothalamic-pituitary-adrenal (HPA) axis. It has been 
hypothesized that dysregulation of the HPA axis during withdrawal and abstinence may 
contribute to altered sensitivity to stress and negative affective states, which are 
characteristics that can enhance the probability of relapse (Adinoff et al. 1998; Adinoff et al. 
2005b; Costa et al. 1996; Koob 2000; Sillaber and Henniger 2004). 
 The HPA axis is a critical system by which the brain activates the physiological 
response to stressors. The physiological stress response is an adaptive mechanism that 
allows organisms to react to harmful or potentially harmful stimuli and to return to a 
homeostatic state following reaction to a stressor. When the brain perceives a stressor, the 
hypothalamus secretes corticotropin-releasing factor (CRF), which stimulates the pituitary 
gland to release adrenocorticotropic hormone (ACTH). ACTH, in turn, activates the adrenal 
cortex to release glucocorticoids (cortisol in humans, corticosterone in rodents). 
Glucocorticoids have myriad central and peripheral effects, including providing negative 
feedback via the glucocorticoid receptor type II (GR) to inhibit the release of CRH and ACTH 
(Tsigos and Chrousos 2002). Dysregulation can occur at each level of the axis producing 
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varied effects, and evidence suggests that alcohol is capable of producing dysregulation of 
the HPA axis via several mechanisms (Sillaber and Henniger 2004).  
 While many people report stress-relief as a motivation for drinking alcohol, the 
effects of alcohol consumption on the stress response are unclear (Pohorecky 1991). Both 
human and animal studies have shown inconsistent results regarding the effects of acute 
and chronic alcohol consumption on stress hormones. While the majority of studies on 
interactions between stress and alcohol have focused on the effects of stress on active 
alcohol consumption (Sillaber and Henniger 2004), alterations of the HPA axis during 
abstinence have been demonstrated in human alcoholics. It is generally thought that alcohol 
and acute alcohol withdrawal produce hyper-reactivity of the HPA axis, and that abstinent 
alcoholics have a hypo-reactive HPA axis, as indicated by decreased responsivity to 
stimulation at each level of the axis (Adinoff et al. 2005a; Adinoff et al. 2005b). In rats, 
chronic daily consumption of alcohol-containing liquid diet and withdrawal produced 
suppression of the HPA axis during abstinence that persisted for up to 3 weeks (Rasmussen 
et al. 2000). The current literature, however, is lacking studies on the effects of abstinence 
following alcohol consumption in non-dependent subjects. Further studies of HPA axis 
alterations during abstinence are necessary to gain a more complete understanding of the 
mechanisms and consequences of abstinence-induced HPA axis dysregulation, including 
the effects of abstinence following moderate voluntary alcohol. 
 In the present study, we investigated HPA axis basal functioning and responsivity 
during abstinence following chronic voluntary drinking. Mice were allowed to self-administer 
alcohol vs water in the home cage following a two-bottle drinking procedure for 28 days. At 
the end of the drinking period, alcohol bottles were removed, and mice experienced a 14 
period of forced abstinence. We examined 24-hr corticosterone rhythmicity on the 14th day 
of abstinence, sensitivity of the HPA axis to dexamethasone following 14 days of 
abstinence, and the behavioral and stress hormonal response to chronic exogenous 
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corticosterone administration during abstinence. These studies were designed to determine 
if the HPA axis is dysregulated during abstinence following moderate voluntary alcohol 
drinking.  
 
METHODS 
Animals 
Adult male C57BL/6J mice (The Jackson Laboratory, Bar Harbor, ME) were singly 
housed in standard Plexiglas cages with Purina Rodent Chow and fluid always available. 
Mice were 9 weeks old at the start of all experiments, and weighed between 22-26g at the 
beginning of the experiments.  At the end point of experiments, mice weighed between 25-
31g.  The vivarium was maintained at 27ºC on a reverse 12:12 light-dark cycle (lights on at 
22:00). Animals were under continuous care and monitoring by veterinary staff from the 
Division of Laboratory Animal Medicine at UNC-Chapel Hill, and all procedures were also 
carried out in accordance with the NIH Guide to Care and Use of Laboratory Animals 
(National Research Council, 1996) and institutional guidelines.  
Experimental Procedures 
24-hr corticosterone rhythmicity. (Figure 16) In the first set of experiments, mice were 
weighed and handled daily for 7 days prior to experiments to facilitate adaptation to the 
laboratory. Animals were then randomly assigned to either alcohol- or water-drinking 
groups.  Alcohol-drinking mice (n=18) were allowed to voluntarily consume alcohol or water 
for 28 days using a two-bottle drinking procedure (see Two-Bottle Drinking section below) 
followed by a 14 day period of forced abstinence, during which only one bottle of water was 
on each cage; water-drinking mice (n=18) had access to two bottles of water for 28 days 
followed by a 14 day period when they had access to only one bottle of water. At the end of 
the 13th day of abstinence, mice were assigned to one of three subgroups (n=6 alcohol and 
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n=6 water per group). Tail blood was collected every 2-hr for 24-hr, but the subgroups were 
staggered such that tail blood was collected from each mouse every 6-hr (Dalm et al. 2005). 
Serum was analyzed for CORT levels to determine the diurnal CORT rhythmicity as a 
function of abstinence following alcohol drinking.  
 Sensitivity to dexamethasone following the abstinence period. (Figure 16)In the 
second set of experiments, mice were again allowed to acclimate to the vivarium conditions 
then assigned to alcohol- or water-drinking groups. Mice drank alcohol vs. water or water vs. 
water for 28 days, and then had access to only one bottle of water for 14-d. On the night 
before the 14th day of abstinence, mice were injected with dexamethasone (n=12 water, 
n=12 alcohol), or vehicle (n=12 water, n=12 alcohol). 6 hrs later (morning of day 14), trunk 
blood was collected to determine CORT suppression in response to the dexamethasone 
injection.   
Response to corticosterone administration during abstinence. (Figure 16) The thrid 
set of experiments followed the same procedures as the first set through the 28 days of 
alcohol or water drinking. At the end of 28th day of drinking, all bottles were removed from 
both alcohol- (n=36) and water drinkers (n=36). Mice were then randomly assigned to one of 
three CORT administration groups. Beginning the same day that alcohol/water bottles were 
removed, mice were given one bottle of CORT-containing water (0 μg/mL, 2.5 μg/mL, and 
5.0 μg/mL; n=12 alcohol-drinkers and n=12 water-drinkers per dose) as their only available 
fluid for the 14 day abstinence period. On day 11 of CORT administration, tail blood was 
collected from all mice to establish a pre-stressor CORT level. On day 14 of CORT 
administration, mice were subjected to the forced swim test (FST) for six minutes, and then 
trunk blood was immediately collected for analysis of post-stressor CORT levels.  
Two-Bottle Drinking Procedure 
 During the one week period of acclimation and handling, water was the only fluid 
available. All fluids were presented in the home cage via 50mL plastic centrifuge bottles with 
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stainless steel sipper tubes. Alcohol-drinking mice were then given access to one bottle of 
water and one bottle of alcohol (10%v/v) as previously described (Hodge et al. 1999). 
Animals were weighed and the fluid levels in the bottles were monitored to the nearest 0.5 
mL at 24-hr intervals to determine daily fluid intake (mL and g/kg). The position (left-right) of 
the alcohol and water bottle was changed each day to control for side preferences. C57Bl/6J 
mice were given access to alcohol for 28 days. We have previously reported that, using this 
method of alcohol administration, mice consume an average of 15 mg/kg/day and achieve 
peak blood alcohol concentrations of 100-150 mg/dL (Stevenson et al., 2008). Control 
animals had access to two bottles of water for the same duration (28 days). On the final day 
of drinking, the alcohol solution-containing bottle was removed from the cages of alcohol 
drinkers, and one water bottle was removed from the cages of controls; thus, during 
abstinence only one bottle of water was on each cage.   
Dexamethasone Suppression Test 
 On the 14th day of abstinence, mice were given a subcutaneous injection of 
dexamethasone (0.1 mg/kg, 10 mL/kg dexamethasone 21-phosphate disodium salt, Sigma-
Aldrich, Inc, St. Louis, MO) or vehicle (saline) at 2:00 am, and immediately returned to the 
home cage. 6-hr later at 8:00 am, mice were rapidly decapitated and trunk blood was 
collected to determine post-dexamethasone injection CORT levels. This method is based on 
Groenink et al., 2002.  
Corticosterone Administration during Abstinence 
 Mice were given access to one bottle containing 0, 2.5, or 5.0 μg/mL  CORT in the 
home cage ad libitum for 14-d beginning as soon as alcohol and water bottles were 
removed. Corticosterone (4-pregnen-11β, 21-diol-3, 20-dione 21-hemisuccinate, Steraloids, 
Inc, Newport, RI) was dissolved in distilled de-ionized water (2.5 μg/mL, and 5.0 μg/mL). 
Solution was brought up to a pH of 12.0 and allowed to stir for 1 hour, and then the pH was 
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brought down to 7.0-7.4. Mice were given fresh water or CORT solution every three days 
(method developed by S.Gourley).  
Tail-bleeding 
 On day 11 of abstinence/CORT administration, tail blood was collected to assess 
pre-stress levels of CORT. Blood collection was performed between 4:00 and 5:00 pm. 
Each mouse cage was taken into a procedure room, then the mouse was placed into a 
restrainer, and blood collection was started within 45 seconds of first touching the cage. 1-
2mm of the distal tail end was removed using a scalpel blade, and 100 μL of blood was 
collected using heparinized capillary tubes, and then placed on ice until blood collection 
from all animals was completed. As soon as the capillary tube was full, light pressure was 
applied to the end of the tail using sterile gauze, and the mouse was returned to the home 
cage and brought back to the vivarium. When blood collection from all animals was 
completed, samples were spun in a centrifuge for 5 minutes at 3,000 rpm, and then frozen 
at -20ºC until CORT assay was performed.   
Forced Swim Test Procedure 
On the 14th day of abstinence/CORT administration, mice were subjected to the 
forced swim test (FST) to measure depression-like behavior, as well as the CORT response 
to the swim stressor (Porsolt et al. 1977). The FST was performed between 4:00 and 5:00 
pm. Mice were placed in a 2000mL beaker containing 1300mL of water maintained at 23-
25°C for 6 minutes. Behavior was videotaped for later analysis by two trained observers who 
were blind to the treatment conditions. The duration of immobility during the last 4 minutes 
of the FST was measured during a single session as an index of depression-like behavior. 
Mice were considered immobile if they were completely still except for small movements of 
the paw made only to keep the mouse afloat, and not producing any noticeable propulsion 
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of the mouse.  Immediately following the FST, mice were brought into a procedure room and 
trunk blood was collected.  
Trunk Blood and Brain Tissue Collection 
 At the endpoint of each experiment, mice were rapidly decapitated and trunk blood 
was collected into heparin-coated microfuge tubes. Blood samples were placed on ice until 
blood collection from all animals was completed. Immediately after decapitation, brains were 
removed, snap frozen in isopentene cooled to -40°C by dry ice, wrapped in aluminum foil, 
and placed on dry ice until all brains had been collected. After blood and brain collection 
from all animals was completed, brain tissue was stored at -80°C, and blood samples were 
spun (5 min at 3,000 rpm) and serum was removed and frozen at -20°C.  
Assessment of Serum Corticosterone 
 Serum was analyzed for CORT content using a radioimmunoassay (MP Biomedicals, 
Irvine, CA) exactly according to kit instructions. All data are expressed as ng/mL. 
Statistical Analyses  
Data were analyzed using two-way ANOVA . Post-hoc Tukey tests were used to 
determine between-group differences. Statistical significance was always defined as p<0.05.   
 
RESULTS  
24-hr corticosterone rhythmicity is not altered by abstinence following chronic 
alcohol drinking.  
Serum CORT levels were measured every 2-hr for 24-hr to determine the circadian 
rhythm and to evaluate the effects of abstinence following alcohol drinking on CORT 
rhythmicity. A two-way ANOVA revealed that there was a main effect of time 
[F(13,134)=9.75, p<0.0001] on serum corticosterone levels, but no main effect of treatment. 
Serum CORT, therefore, did not differ between alcohol-drinking and water-drinking mice at 
any time point over the course of 24-hr (Figure 17). These data indicate that the circadian 
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rhythm of CORT is not altered by two weeks of abstinence following chronic voluntary 
ethanol drinking.  
Sensitivity to dexamethasone is not altered by abstinence following voluntary 
drinking.  
 The response of the HPA axis to administration of the exogenous glucocorticoid, 
dexamethasone, was determined at the end of the 14-d abstinence period. A two-way 
ANOVA showed a main effect of dexamethasone on serum CORT [F(1,43)=19.508, 
p<0.001] (Figure 18). A history of 28-d voluntary alcohol drinking had no effect on sensitivity 
to dexamethasone.  
14-d corticosterone administration alters basal serum corticosterone, post-stressor 
serum corticosterone, and behavior in the forced swim test. 
Corticosterone (0, 2.5, or 5.0 μg/mL) was administered to mice via the drinking water 
for 14-d. Mice consumed an average of 5.79 ± 0.08 mL of fluid, and fluid consumption did 
not differ based on dose of corticosterone or drinking history. A two-way ANOVA revealed a 
main effect of dose of CORT in drinking water on the amount of CORT (but not the amount 
of fluid) consumed [F(1,44)=255.3, p<0.001], but there was no main effect of drinking history 
on CORT consumption. This indicates that mice consumed a higher amount of 
corticosterone only because the dose of CORT in their drinking water was higher (data not 
shown).  These data indicate that total fluid intake was not altered by a history of alcohol 
drinking or by the dose of corticosterone administered and that consumption of 
corticosterone was not affected by drinking history.  
Basal serum corticosterone levels were measured following 11 days of CORT 
consumption via the drinking water.  A two-way ANOVA showed a main effect of dose of 
CORT in drinking water on basal serum CORT levels [F(2,30)=16.401, p<0.001], but no 
main effect of drinking history (Figure 19a). Follow up comparisons revealed that basal 
serum CORT was significantly higher in mice that drank 5.0 μg/mL solution compared to 0.0 
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μg/mL CORT solution (p<0.001, Tukey test) and 2.5 μg/mL CORT solution (p=0.038, Tukey 
test). Also, mice that drank a 2.5 μg/mL CORT solution had significantly higher basal CORT 
levels compared to mice that drank 0.0 μg/mL CORT solution (p=0.011, Tukey test).  These 
data indicate that basal serum CORT levels were increased in a dose-dependent manner by 
consumption of corticosterone in the drinking water, and were not affected by a history of 
alcohol drinking.  
Stress-induced serum corticosterone levels were also measured on day 14 of CORT 
administration following the FST. A two-ANOVA showed a main effect of dose of CORT in 
drinking water on stress-induced serum CORT levels [F(2,65)=14.43, p<0.001], but no main 
effect of drinking history (Figure 19b). Follow up comparisons revealed that stress-induced 
serum CORT was significantly lower in mice that drank 5.0 μg/mL CORT solution compared 
to 0.0 μg/mL and 2.5 μg/mL CORT solution (p<0.001,  and p=0.021, respectively, Tukey 
test). Also mice that drank a 2.5 μg/mL CORT solution had significantly lower stress-induced 
CORT levels compared to mice that drank 0.0 μg/mL CORT solution (p=0.034). The data 
suggest that consumption of CORT via drinking water blunts stress-induced CORT levels in 
a dose-dependent manner, and that this effect is not altered by a history of alcohol drinking. 
The response to stress was measured by comparing the change in serum CORT 
between basal levels and post-stress levels. The two-way ANOVA showed only a main 
effect of the dose of CORT in the drinking water [F(2,30)=11.234, p<0.001] (Figure 19c). 
The difference between pre- and post-stressor serum CORT levels was significantly smaller 
in mice that drank 5.0 μg/mL CORT solution compared to 0.0 μg/mL CORT solution 
(p<0.001, Tukey test). The change in pre- and post-stressor serum CORT levels showed a 
strong trend toward a decrease in mice that drank 2.5 μg/mL CORT solution compared to 
0.0 μg/mL CORT solution (p=0.067, Tukey test) and in mice that drank 5.0 μg/mL CORT 
solution compared to 2.5 μg/mL CORT solution (p=0.057, Tukey test), but these decreases 
were not significant. Again, there was no main effect of drinking history on the change in 
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CORT. These data indicate a dose-dependent decrease of the stress response, as indicated 
by change in CORT pre- and post-stressor, as a result of 14-d of CORT consumption via the 
drinking water.  
Depression-like behavior in the FST was measured on the 14th day of abstinence 
following chronic drinking/CORT administration. A two-way ANOVA showed a main effect of 
dose of CORT in the drinking water on immobility in the FST [F(2,64)=3.708, p=0.03], but no 
main effect of drinking history on immobility (Figure 19d).  Follow up comparisons indicated 
that immobility was significantly increased in mice that drank 5.0 μg/mL CORT solution 
compared to 0.0 μg/mL CORT solution (p=0.027, Tukey test). These data indicate that 
consumption of 5.0 μg/mL CORT solution for 14-d increases immobility in the FST, 
suggesting that low dose chronic CORT consumption can produce increased depression-
like behavior.  
 
DISCUSSION 
 The current study investigated the HPA axis of two-week abstinent mice that had 
voluntarily consumed alcohol for 28 days. Dysregulation of the HPA axis is known to occur 
in both actively drinking and abstinent alcoholics. It is not known, however, what level of 
consumption or dependence is required to produce alterations of the HPA axis during 
abstinence. The only studies investigating the HPA axis during abstinence have examined 
human subjects that were already alcoholic, and rats that were made dependent via chronic 
liquid diet alcohol consumption (Adinoff et al. 2005b; 2005c; Costa et al. 1996; Rasmussen 
et al. 2000). The effects of abstinence following voluntary moderate alcohol consumption on 
the HPA axis have not been studied. The experiments presented in the current study were 
designed to model early stage alcohol abuse to determine if abstinence following chronic 
moderate alcohol drinking contributes to alcohol-related HPA dysfunction.  
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  Our data indicate that abstinence following chronic voluntary drinking is not 
associated with a shift in the circadian rhythm of CORT levels. Because CORT levels 
change so drastically throughout the 24-hr period, it was important to establish that the 
diurnal rhythm of CORT was not altered so that blood samples collected at the same time 
point in abstinent and control mice could be compared without accounting for circadian 
rhythm shifts. Alcoholism is associated with significant alterations in sleep and the circadian 
rhythm-dependent biological processes including the rhythmicity of melatonin and 
glucocorticoids, and core temperature (Brower 2001; Fonzi et al. 1994; Rosenwasser et al. 
2005). Studies have also demonstrated that alterations of these circadian rhythm-dependent 
biological processes are associated with an increased risk for relapse (Brower 2001; 2003; 
Fonzi et al. 1994; Gillin et al. 1994; Rosenwasser et al. 2005). Our data demonstrate that 
abstinence following 28-d of voluntary drinking does not produce shifts in the circadian 
rhythm of CORT, nor does it produce changes in basal levels of CORT at any point 
throughout the 24-hr period. This suggests that alterations of basal CORT and CORT 
rhythmicity may not occur until later stages of alcohol abuse/dependence.   
 While changes in basal CORT production were not evident in two-week abstinent 
mice, we wanted to determine if abstinence following chronic moderate drinking produced 
vulnerabilities in the HPA axis. To investigate this possibility, we administered corticosterone 
to the mice throughout the abstinence period via their drinking water and then measured 
their CORT response following to an acute stressor.  Our findings demonstrate that alcohol-
abstinent mice did not differ from control mice in their basal response to chronic CORT 
administration (as measured by serum CORT following 11 days of CORT consumption), nor 
did they differ in their post-stressor CORT levels. Furthermore, the level of depression-like 
behavior exhibited in the forced swim test was not different in mice with a history of alcohol 
drinking. Repeated CORT administration may be a model of chronic stress, and has been 
shown to produce depression-like behavior at higher doses (Gourley et al. 2008). The data 
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presented here indicate that abstinence following chronic voluntary alcohol drinking does not 
produce altered vulnerability to chronic challenge of the HPA axis.  
Though no differences were found in the HPA axis response between control and 
alcohol-abstinent mice,  our data do suggest that even very low dose CORT consumption 
(2.5 μg/mL and 5.0 μg/mL) for two-weeks produces robust changes in basal CORT, post-
stress CORT, and the expression of depression-like behavior. It has been previously 
demonstrated that repeated CORT administration increases immobility in the FST in rats 
and mice, and that these effects are dose-dependent (Gregus et al. 2005; Hill et al. 2003; 
Zhao et al. 2008). These previous studies, however, used significantly higher doses of 
CORT (20-40 mg/kg), and administered CORT via injection. Our method of CORT 
administration produced physiologically relevant serum CORT levels similar to those 
achieved via models of chronic mild stress (100-130 ng/mL) (Grippo et al. 2005). The 
findings of the current study also demonstrate that chronic low dose CORT administration 
via the drinking water produces dose-dependent elevations in basal serum CORT, dose-
dependent reductions of CORT secretion in response to a stressor, and increased 
depression-like behavior. Elevated basal CORT with a decreased response to HPA 
activation is common in depressed people (Gillespie and Nemeroff 2005), indicating that 
administration of low dose chronic CORT administration via the drinking water in mice may 
be useful as an animal model of HPA dysfunction during depression.  
In contrast to our findings, it was recently reported that administration of low dose 
CORT via the drinking water produced reductions in immobility in the FST (Stone and Lin). 
In these experiments, however, CORT was administered for only 2-4 days before the FST.  
Taken together with the findings presented here these data support a hypothesis previously 
suggested by other researchers, that low dose CORT administration has significantly 
different effects when given subchronically and acutely, rather than chronically. Low dose 
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and or acute glucocorticoid administration may be antidepressant, while chronic 
glucocorticoid administration, even if given at low doses, may have pro-depressant effects.  
When dexamethasone was administered at the end of the abstinence period, we 
found robust suppression of serum CORT 6-hr later. These data are similar to the findings of 
Groenink et al. (2002), except that we did not find complete suppression of CORT at a dose 
of 0.1 mg/kg dexamethasone, but rather suppression of 60-75% of control values. There 
was no difference in the amount of suppression of CORT exhibited by control and alcohol-
abstinent mice. These data again suggest that dysregulation of the HPA axis does not occur 
after two-weeks of abstinence following chronic moderate alcohol drinking.  
In this study, however, we chose to focus our investigation of stress-related 
adaptations during abstinence on the HPA axis, although important extra-hypothalamic 
stress responses exist within the central nervous system, and are known to be affected by 
alcohol and abstinence following chronic alcohol consumption. These mechanisms include 
alterations in CRF in the amygdala, a region known to be involved in emotionality and fear 
processing. Changes in gene transcription and synaptic plasticity and structure in the 
hippocampus, nucleus accumbens, and other brain regions have also been reported in 
response to both stress and alcohol (Koob and Le Moal 2008; Pandey 2004; Stevenson et 
al.). Future studies could examine these extra-hypothalamic changes during abstinence 
following chronic voluntary drinking.  
Because alterations of the HPA axis in abstinent alcoholics are associated with 
increased risk for relapse (Adinoff et al. 1998), it is important to establish why and when 
these alterations occur in the disease course of alcoholism. Data in rats suggest that 
alterations of the HPA axis in abstinence can occur as the result of alcohol abuse itself in 
addition to genetic predisposition to HPA axis dysregulation (Rasmussen et al. 2000); 
however these studies do not indicate how much alcohol drinking is required to produce 
HPA axis dysfunction in abstinence. Our data suggest that a greater level of dependence 
 65
than was achieved after one month of voluntary drinking in mice is required before 
abstinence in order for the HPA axis to become dysregulated. It is possible that a longer 
course of drinking (more than 28-d) would lead to HPA axis dysfunction upon cessation of 
drinking. Similarly, it is possible alcohol intake could be increased to levels that produced 
dependence using an intermittent or limited access alcohol drinking procedure, and that this 
would cause alterations of the HPA axis upon cessation of alcohol drinking. Furthermore, if 
we had evaluated the HPA axis earlier in the abstinence period, we might have seen 
measurable dysregulation. Additionally, as several studies have indicated that genetics may 
predispose alcoholics to HPA axis dysregulation (Gianoulakis 1998; Schuckit and Monteiro 
1988; Schuckit et al. 1997a; Schuckit et al. 1997b; Waltman et al. 1994), it could be the case 
that HPA axis dysregulation occurs more readily in a subset of alcoholics who are 
genetically or environmentally predisposed to dysregulation of the HPA axis. Future studies 
including multiple alcohol drinking procedures, longer durations of alcohol drinking and 
abstinence, as well as studies using multiple strains of mice are warranted to better 
understand the processes by which alcohol consumption and abstinence produce HPA axis 
dysregulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER V: DISCUSSION 
 
CONCLUSIONS 
Neuroadaptations occur not only during active alcohol drinking, but also during 
abstinence following chronic alcohol drinking. It is thought that these abstinence-induced 
changes can enhance the vulnerability to relapse. The studies presented here examined the 
emergence of negative affect during abstinence, and found that mice exhibit depression-like 
behavior 14-days after cessation of chronic voluntary alcohol drinking. In addition, 
decreased hippocampal neurogenesis is evident following 14-days of abstinence. Both of 
these abstinence-induced changes are prevented if the antidepressant desipramine is 
administered chronically throughout the abstinence period. In several brain regions, the 
expression and phosphorylation of the transcription factor CREB are altered in response to 
abstinence and desipramine administration. These abstinence-induced alterations occur in 
the absence of measurable HPA axis dysfunction. Understanding the behavioral and 
neuroadaptive changes occurring during abstinence may help develop proper treatments for 
alcohol abusers who are in the process of discontinuing alcohol use.  
Our studies demonstrating the emergence of depression-like behavior after 14-days 
of abstinence provide a model for investigating how alcohol consumption (or cessation of 
alcohol consumption) is related to depression. Given the large percentage of patients who 
suffer from comorbid alcoholism and depression (Schuckit et al. 1997a), it is essential that 
we have a better understanding of the neurobiological mechanisms underlying this 
comorbidity. These data indicate that alcohol-related depression may emerge as a 
consequence of the process of chronic drinking followed by cessation of chronic drinking, 
and does not appear to require a pre-existing or genetic condition. The efficacy of 
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desipramine, a NE reuptake inhibitor, in preventing the emergence of depression-like 
behavior as well as change in neurogenesis validates these conditions as depression-
related, and suggests that both conditions can be modulated by enhancement of 
monoaminergic neurotransmission.  Accordingly, we investigated changes in CREB that 
result from abstinence and desipramine treatment, as CREB is downstream of monoamine 
receptor activation.  
Analysis of CREB and pCREB immunoreactivity (IR) revealed subregionally distinct 
changes in response to both abstinence following alcohol drinking and chronic desipramine 
treatment. CREB alterations resulting from abstinence following chronic alcohol drinking 
were limited to the hippocampus. CREB and pCREB were slightly increased in the dentate 
gyrus and the CA1, but robustly decreased in the CA3 following 14-days of abstinence. 
Desipramine treatment alone, on the other hand, increased CREB and pCREB IR in the 
dentate gyrus, CREB IR in the CA1. While desipramine treatment did not affect CREB in the 
CA3, it did completely prevent abstinence-induced changes. These data highlight the 
hippocampus as a brain region that is sensitive to abstinence following chronic alcohol 
drinking and that can be protected by antidepressant treatment.  
Decreased neurogenesis is another example of hippocampal neuroadaptations that 
result from abstinence following chronic alcohol drinking. Our data indicate that chronic 
moderate alcohol drinking itself does not lead to changes in neurogenesis, but abstinence 
following chronic moderate alcohol drinking produces decreased neurogenesis. As 
decreased neurogenesis has been proposed as a mechanism underlying depression, 
abstinence-induced decreased neurogenesis may be a neuroadaptation which promotes 
negative affect in alcoholics who try to stop drinking.  
Changes in CREB and pCREB IR in other brain regions such as the amygdala and 
the nucleus accumbens occur in response to desipramine treatment, but are unrelated to 
abstinence following alcohol drinking. This does not necessarily indicate that the amygdala 
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and the nucleus accumbens are not affected by abstinence, but it does suggest that any 
changes that may occur are not mediated by the transcription factor CREB at the time point 
we examined. It is possible, however, that CREB-related changes occurred in these brain 
regions earlier in abstinence and/or during alcohol drinking, and that these changes 
precipitated the hippocampal adaptations that occur following 14-days of abstinence. In 
particular, it would be expected that dysregulation might occur in the amygdala early in 
abstinence. As indicated in the first set of experiments, mice exhibit anxiety-like behavior 
following 24-hours of abstinence, but this behavioral effect dissipates by the 14th day of 
abstinence. These data suggest and are in agreement with many previous studies indicating 
dysregulation of the brain stress system in early abstinence. In particular, alterations in CRF 
expression and CREB phosphorylation in the CeA have been demonstrated to produce 
withdrawal-related anxiety (Becker 2000; Koob and Le Moal 2008; Pandey 2004). It is 
possible that activation of such extra-hypothalamic stress circuits during the initial phase of 
abstinence is responsible for the presence of anxiety-like behavior one day after cessation 
of alcohol drinking in our experiments. It is also possible that activation of extra-
hypothalamic stress circuits promotes the hippocampal and behavioral deficits that are 
evident after two weeks of abstinence, but further studies are warranted to evaluate this 
hypothesis.  Our investigations of the HPA axis during abstinence, however, would suggest 
that the HPA axis is not responsible for the increased depression-like behavior and 
decreased hippocampal neurogenesis after 14 days of abstinence.  
It is unclear from the present studies if decreased neurogenesis in the dentate gyrus 
and decreased CREB in the CA3 region of the hippocampus are directly related. Previous 
studies have demonstrated that certain types of stressors can lead to both decreased 
neurogenesis in the dentate gyrus and dendritic retraction in the CA3 (McEwen 2001), but it 
is not known if these changes share a parallel or a causal relationship. Because new 
neurons in the dentate gyrus project to the CA3 region (to make up the mossy fiber 
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pathway), it is conceivable that a decrease in this input to the CA3 could be responsible for 
the decrease in an activity-dependent signaling molecule such as CREB. It remains 
unknown, however, what the consequences of decreased neurogenesis are to CREB 
signaling in other subregions of the hippocampus.  
Although two weeks of abstinence following a month of moderate voluntary alcohol 
drinking is not sufficient to promote dysregulation of the HPA axis, it is sufficient to produce 
significant hippocampal and behavioral adaptations. These include the emergence of 
negative affect, as well as impairment of structural and transcription-related mechanisms. 
These deficits warrant further investigations into the consequences of abstinence following 
even moderate drinking, and suggest that alcohol abusers may be at risk if they attempt to 
stop drinking, even when they have not become severely dependent.   
LIMITATIONS AND FUTURE DIRECTIONS 
 While the research presented in this dissertation highlights some of the important 
cellular and behavioral changes that can occur in abstinence following chronic alcohol 
drinking, there were limitations to these studies that we plan to address in future 
experiments. First, the FST data presented in chapter 2 indicates the emergence of negative 
affective states beyond the initial withdrawal phase of abstinence, but a more complete 
characterization of these behavioral changes is warranted. We chose to focus of the FST 
because it is an assay of depression-like behavior that can be tested at a discrete time-point 
and that does not require a training period. Additional measures that will be important to 
conduct include assessing vulnerability to development of learned helplessness in the shock 
avoidance procedure and development and expression of anhedonia, as well as 
characterization of novelty exploratory behavior, as these are all measures that can assess 
a shift from positive motivational states to negative stress system-driven states (Stone et al. 
2008). Such behavioral test will help define the extent and nature of abstinence-induced 
negative affective states.  
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 Similarly, the time course for emergence of negative affect during abstinence needs 
further characterization. It will be important to define when in during abstinence these 
behaviors first emerge and how long they persist following cessation of drinking. 
Additionally, the studies presented here indicate that even moderate alcohol, when 
consumed chronically, can produce these behavioral and cellular deficits in abstinence; thus 
the duration and dose of alcohol sufficient to produce these changes should be explored. In 
addition, a more detailed time course of abstinence-induced changes in neurogenesis would 
be helpful in understanding the parameters of vulnerability for the hippocampus following 
cessation of alcohol drinking.  
 While the alterations in CREB and pCREB IR in multiple brain regions following 
abstinence and desipramine treatment indicate changes in gene transcription, further 
studies examining expression of some of the CREB target genes will be useful in 
determining the consequences of these CREB-related changes. It would be especially 
interesting to measure expression of BDNF (thought to be involved in neurogenesis and 
overall healthy neuronal functioning), and CRF and dynorphin which may play important 
roles in abstinence-induced negative affective states (Carlezon et al. 2005; Koob and Le 
Moal 2008). Furthermore, studies of CRF and CRF receptor expression during abstinence 
following chronic moderate alcohol drinking are warranted as studies have suggested that 
alterations in these proteins may be associated with the anxiety and stress-related changes 
in early abstinence and withdrawal, and these changes may precipitate the emergence of 
depression-like behavior later in abstinence.  
 Ultimately, the work presented in this dissertation provides initial evidence of 
neuroadaptations in abstinence following drinking in mice that are not severely dependent. 
These data provide the foundation and the impetus for further studies of behavioral and 
cellular adaptations that may contribute to the development of alcohol addiction.  
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Table 1. Anxiety-like behavior and locomotor activity. 
 
 
 
 
 
Table 1. Anxiety-like behavior and locomotor activity. Mice spent significantly less time in 
the center of an open field following 1 day of abstinence compared to control animals, 
indicating increased anxiety-like behavior following 1 but not 14 days of abstinence following 
chronic voluntary alcohol drinking. Total locomotor activity did not differ between any of the 
groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment 
Group Time in center (sec) 
Total locomotor 
(cm) 
control 190.2 ± 17.6 4668.9 ± 245.6 
alcohol+1day 90.75 ± 10.2* 5402.8 ± 242.9 
alcohol+14days 147.9 ± 12.1 4503.5 ± 204.7 
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Figure 1. Periods of abstinence in the disease course of alcoholism. 
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Figure 1. Periods of abstinence in the disease course of alcoholism. a. The 
neuroadaptations that occur during abstinence following chronic drinking may increase the 
risk for subsequent relapse. The blue arrow indicates a period of withdrawal and abstinence 
in a dependent alcoholic. The characteristics of early withdrawal are fairly well characterized 
and include overactivation of the autonomic nervous system and the HPA axis and anxiety. 
The changes that occur during more protracted abstinence are not as well understood. b. 
The neuroadaptations that occur during abstinence following chronic drinking in subjects 
that are not severely dependent have not been characterized. The blue arrow indicates a 
period of protracted abstinence in a non-dependent alcoholic. This period of abstinence is 
the focus of the experiments described in this dissertation.  
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Figure 2. Intracellular signaling pathways activated by alcohol and antidepressants. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Intracellular signaling pathways activated by alcohol and antidepressants. Both 
alcohol and antidepressants produce changes in intracellular signaling pathways by 
activating or inhibiting G-protein-coupled-receptors (GPCRs). These signaling changes and 
alter the level of CREB-dependent transcription to produce long term changes in gene 
expression. Moreover, changes in the expression of trophic factors, such as brain-derived-
neurotrophic-factore (BDNF) are thought to lead to parallel changes in neurogenesis.  
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Figure 3. Timeline of experimental procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Timeline of experimental procedure. Each stage of the experiment is labeled as a 
separate section in the arrow. The duration of each stage (Number of Days) is shown under 
the arrow. (A) After 7 days of adaptation to the lab, mice received daily injections of BrdU 
(300 mg/kg, I.P.) for 3 days. The following day, the two-bottle drinking procedure began. 
Mice voluntarily self-administered alcohol versus water in the home cage for 28 days. On the 
28th day, alcohol bottles were removed from the cage. One day later or 14 days later, 
locomotor activity and forced swim tests were perfomed. The following day, mice were 
sacrificed, and brains were removed. (B) After 7 days of adaptation to the lab, mice began 
28 days of a two-bottle drinking procedure. On the 28th day, alcohol bottles were removed 
and mice received their first injection of either vehicle or desipramine (15 mg/kg, I.P.). 
Injections were given once daily for 14 days. 1 day after the last injection, locomotor activity 
and forced swim tests were performed. One day later, mice were sacrificed, and brains were 
removed. 
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Figure 4. Abstinence from alcohol drinking increases depression-like behavior. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Abstinence from alcohol drinking increases depression-like behavior. Mean 
immobility (sec) in the Forced Swim Test (FST) increased as a function of days of 
abstinence from alcohol drinking as compared to water-drinking controls. Data are plotted as 
mean ± SEM from n=12 mice in each condition. * - significantly different from water-drinking 
control, p<0.05 (Dunnett’s t-test). 
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Figure 5. No changes in survival of NPCs. 
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Figure 5: No changes in survival of NPCs. (A). The mean number of BrdU-labeled cells that 
survive is unchanged in the dentate gyrus following voluntary drinking and 1-d or 14-d 
abstinence. (B) Representative images showing BrdU-labeled cells in the dentate gyrus 
from control, 1 day of abstinence, and 14 days of abstinence. (C) Triple-label 
immunofluorescence was used to evaluate differentiation of surviving NPCs. A 
representative dentate gyrus is shown.  GFAP-labeled glial cells are shown in blue, NeuN-
labeled neuronal nuclei are shown in red, BrdU-labeled cells are shown in green. (D) An 
orthogonal view of a representative cell showing colocalization of BrdU and NeuN. The 
number of surviving BrdU-labled cells that co-labeled with the neuronal marker NeuN was 
unchanged in ethanol-treated brains. Data are plotted as mean 
± SEM from n=9-12 mice in each condition. 
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Figure 6. Abstinence from alcohol reduces adult hippocampal neurogenesis. PCNA 
and DCX immunohistochemistry. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Abstinence from alcohol reduces adult hippocampal neurogenesis. PCNA and 
DCX immunohistochemistry. (A) Relative change in PCNA immunoreactivity (IR) in the 
dentate gyrus showing a reduction in NPC proliferation as a function of 0, 1, or 14 days of 
abstinence from alcohol drinking. (B) Relative decrease in DCX IR showing that the number 
of new neurons in the dentate gyrus is reduced as a function of abstinence from alcohol 
drinking. (C – D) Representative images of dentate gyrus from control, 0 days, 2 days, and 
14 days of abstinence for PCNA (C) and DCX (D). Arrow heads point to representative 
PCNA-labeled cells. Mean data were obtained from averaging results from 4 tissue sections 
per mouse and plotted as percent change from water-drinking control. * - significantly 
different from water-drinking control, p<0.05 (Dunnett’s t-test). 
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Figure 7. Desipramine treatment prevents abstinence-induced changes in depression-
like behavior and neurogenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Desipramine treatment prevents abstinence-induced changes in depression-like 
behavior and neurogenesis. (A) Abstinence-induced increase in immobility (sec) in the 
Forced Swim Test (FST) was completely blocked by treatment with desipramine during 14 
days of abstinence (n=12 per group). *-significantly different from water-drinking mice that 
received vehicle (desipramine, 0 mg/kg), p=0.007, and significantly different from ethanol- 
15 mg/kg, p=0.008 (Tukey test). (B) Desipramine treatment (14 days) prevented the 
abstinence-induced decrease in PCNA immunoreactivity in the dentate gyrus (n=12 per 
group). *-significantly different from water-drinking mice that received vehicle (desipramine, 
0 mg/kg), p=0.012, (Tukey test). (C) Abstinence-induced reduction in DCX density was 
completely blocked by desipramine during 14 days of abstinence (n=12 per group). *-
significantly different from water-drinking mice that received vehicle (desipramine, 0 mg/kg), 
p=0.004, and significantly different from ethanol- 15 mg/kg, p=0.005 (Tukey test). Mean ± 
SEM data for PCNA and DCX IR were obtained by averaging results from 4 tissue sections 
per mouse and plotted as percent change from water- 0 mg/kg controls. (D) Representative 
photomicrographs of PCNA IR (10X). Black arrows indicate PCNA-labeled cells. (E) 
Representative photomicrographs of DCX IR (10X).  
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Figure 8. Two-bottle drinking procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Two-bottle drinking procedure. (A)The weights of the mice increased significantly 
over the course of 28 days of drinking according to a two-bottle drinking procedure followed 
by two weeks of abstinence, and mouse weights did not differ at any point between water 
drinking and alcohol drinking mice. (B) Total fluid intake was significantly different between 
water and alcohol drinking mice during the two-bottle choice procedure with alcohol drinkers 
consuming an average of 0.5mL of fluid less per day (p<0.001). Mice also consumed 
significantly less total fluid when there was one bottle present on the cage during the two 
weeks of abstinence, probably due to less water dripping from the bottle (p<0.001). 
(C)Alcohol consumption by alcohol drinking mice did not differ over the 28 days of two-bottle 
drinking.  
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Figure 9. CREB changes in the dentate gyrus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: CREB changes in the dentate gyrus. (A) CREB IR was not significantly different in 
the dentate gyrus following abstinence or desipramine treatment. (B) Representative 
photomicrographs of CREB IR (40X). (C) pCREB IR was significantly increased by 14 days 
of desipramine administration compared to vehicle (p=0.003),and by 14 days of abstinence 
from alcohol drinking (p=0.12), with an interaction between alcohol abstinence and 
desipramine treatment (p=0.39). pCREB IR is significantly increased in W+15 compared to 
W+0 (p<0.001) and in A+0 compared to A+15 (p=0.003). (D) Representative 
photomicrographs of pCREB IR (40X). 
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Figure 10. CREB changes in the CA1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: CREB changes in the CA1. (A) Desipramine treatment significantly increased 
CREB IR in the CA1 (p=0.005), with a significant interaction between abstinence and 
desipramine treatment (p<0.001). W+15 were significantly increased compared to W+0 
(p<0.001), and A+0 were significantly increased compared to W+0 (p<0.001), indicating that 
desipramine and abstinence increased CREB in the CA1, but desipramine was not able to 
increase CREB IR beyond abstinence-induced increases. (B) Representative 
photomicrographs of CREB IR (40X). (C) Neither abstinence nor desipramine treatment 
altered pCREB IR in the CA1. (D) Representative photomicrographs of pCREB IR (40X). 
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Figure 11. CREB changes in the CA3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: CREB changes in the CA3. (A) CREB expression was significantly decreased by 
abstinence following chronic alcohol drinking (p=0.003), and that this decrease was 
completely prevented by desipramine treatment (p=0.005).  (B) Representative 
photomicrographs of CREB IR (40X). (C) pCREB IR was significantly decreased by 
abstinence following chronic alcohol drinking (p=0.008), and that this decrease was 
completely prevented by desipramine treatment (p=0.018).  (D) Representative 
photomicrographs of pCREB IR (40X). 
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Figure 12. CREB changes in the Nucleus Accumbens Core. 
 
 
 
Figure 12: CREB changes in the Nucleus Accumbens Core. (A) CREB IR was not altered in 
the NA core by abstinence or desipramine. (B) Representative photomicrographs of CREB 
IR (40X). (C) pCREB IR was significantly increased by desipramine treatment in the core of 
the nucleus accumbens (p=0.031). (D) Representative photomicrographs of pCREB IR 
(40X). 
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Figure 13. CREB changes in the Nucleus Accumbens Shell. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: CREB changes in the Nucleus Accumbens Shell. (A) CREB IR was not altered in 
the NA shell by abstinence or desipramine. (B) Representative photomicrographs of CREB 
IR (40X). (C) pCREB IR was significantly increased by desipramine treatment in the shell of 
the nucleus accumbens (p=0.008). (D) Representative photomicrographs of pCREB IR 
(40X). 
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Figure 14. CREB changes in the Central Nucleus of the Amygdala. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: CREB changes in the Central Nucleus of the Amygdala. (A) CREB IR was not 
altered in the CeA by abstinence or desipramine. (B) Representative photomicrographs of 
CREB IR (40X). (C) pCREB IR was significantly increased by desipramine treatment in the 
CeA (p=0.032). (D) Representative photomicrographs of pCREB IR (40X). 
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Figure 15. CREB changes in the Basolateral Nucleus of the Amygdala. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: CREB changes in the Basolateral Nucleus of the Amygdala. (A) CREB IR was 
significantly increased by desipramine treatment in the BLA (p=0.026). (B) Representative 
photomicrographs of CREB IR (40X). (C) pCREB IR was not altered in the BLA by 
abstinence or desipramine. (D) Representative photomicrographs of pCREB IR (40X). 
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Figure 16. Timeline of experimental procedures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mice 
arrive in 
lab
Two-bottle 
drinking 
procedure begins
Alcohol is 
removed, 
abstinence 
begins
Blood collection 
begins for 24-hr 
period
7 days 28 days 14 days
Time
Day 1 Day 7 Day 35 Day 48-49
Mice 
arrive in 
lab
Two-bottle 
drinking 
procedure begins
Alcohol is 
removed, 
abstinence 
begins
Dexamethasone 
injection, followed 
by decap and blood 
collection 6-hr later
7 days 28 days 14 days
Time
Day 1 Day 7 Day 35 Day 48-49
Mice 
arrive in 
lab
Two-bottle 
drinking 
procedure begins
Alcohol is removed, 
CORT administration 
(0, 2.5, or 5.0 µg/mL) 
begins
FST followed 
by trunk blood 
collection
7 days 28 days 14 days
Time
Day 1 Day 7 Day 35 Day 48-49
Day 45
Tail blood 
collected
Experiment 1
Experiment 2
Experiment 3
Experimental Timelines
 90
Figure 16: Timeline of experimental procedures. (A) Mice were allowed 7 days to acclimate 
to lab conditions before beginning the two bottle drinking procedure. After 28-days of two-
bottle drinking, animals began 14-d of abstinence. At the end of the abstinence period, mice 
were assessed for 24-hr CORT rhythmicity. (B) Mice were allowed 7 days to acclimate to lab 
conditions before beginning the two bottle drinking procedure. After 28-days of two-bottle 
drinking, animals began 14-d of abstinence. At the end of the abstinence period, mice were 
assessed for sensitivity to dexamethasone. (C) Mice were allowed 7 days to acclimate to lab 
conditions before beginning the two bottle drinking procedure. After 28-days of two-bottle 
drinking, animals began 14-d of administration of CORT via the drinking water. On the 11th 
day of CORT administration, baseline serum CORT levels were measured. At the end of 14 
days of abstinence/CORT administration, mice were assessed in the FST and post-stressor 
serum CORT levels were measured.  
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Figure 17. 24-hour serum corticosterone rhythmicity is not altered by abstinence 
following alcohol drinking. 
 
 
 
 
 
 
 
 
Figure 17:  24-hour serum corticosterone rhythmicity is not altered by abstinence following 
alcohol drinking. Serum CORT levels did not differ between alcohol-drinking and water-
drinking mice at any time point over the course of 24-hours of measurement. There was a 
main effect of time on serum CORT levels (p<0.0001). Shaded area shows lights off period. 
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Figure 18. Sensitivity to dexamethasone is not altered by abstinence following 
alcohol drinking. 
 
 
 
 
 
 
 
 
 
Figure 18: Sensitivity to dexamethasone is not altered by abstinence following alcohol 
drinking. Serum CORT levels were significantly suppressed 6 hours after an injection of 
dexamethasone (0.1mg/kg) (p<0.001), but sensitivity to dexamethasone was not different 
between alcohol-drinking and water-drinking mice.  
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Figure 19. 14-d corticosterone administration alters basal corticosterone, post-
stressor corticosterone, and behavior in the forced swim test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: 14-d corticosterone administration alters basal corticosterone, post-stressor 
corticosterone, and behavior in the forced swim test. (A) Pre-stressor serum CORT was 
significantly increased by 14-d consumption of 5.0 μg/mL CORT solution compared to 0.0 
μg/mL (p<0.001), and by 2.5 μg/mL CORT solution compared to 0.0 μg/mL (p=0.038). (B)  
Post-stressor serum CORT was significantly increased by 14-d consumption of 5.0 μg/mL 
CORT solution compared to 0.0 μg/mL (p<0.001), and by 2.5 μg/mL CORT solution 
compared to 0.0 μg/mL (p=0.021). (C)The stress response (as measured by the change in 
serum CORT from pre-stressor to post-stressor levels) was significantly decreased by 14-d 
consumption of  5.0 μg/mL CORT solution compared to 0.0 μg/mL (p<0.001). (D) Immobility 
in the FST was significantly increased by 14-d administration of 5.0 μg/mL CORT solution 
(p=0.03). Pre-and post-stressor serum CORT levels, stress response, and FST behavior 
were not different in alcohol-drinking and water-drinking mice.  
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